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ABSTRACT 
 
ROLES FOR THE ARYL HYDROCARBON RECEPTOR IN THE IMMUNE 
RESPONSE TO TOXOPLASMA GONDII  
Sagie Wagage 
Christopher A. Hunter 
One of the major challenges faced by the immune system involves mounting an 
inflammatory response to control pathogen growth while limiting immune-mediated 
damage to the host. In order to achieve this balance, responding immune cells need to 
detect signals from the environment and react appropriately by promoting or attenuating 
inflammation. Cells of the immune system employ an array of sensors to respond to 
environmental cues, such as nuclear hormone receptors, cytokine receptors, and Toll-like 
receptors. The aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, 
provides immune cells with an additional means of detecting and responding to 
environmental signals to promote immunity. The work presented in this thesis examines 
the effects of AHR signaling during infection with the protozoan parasite Toxoplasma 
gondii, a medically significant pathogen that naturally infects mice. A variety of AHR 
ligands are produced by the host and the parasite during toxoplasmosis, which raised the 
question of whether AHR activity influences the immune response in this setting. Chapter 
2 of this thesis describes a role for the AHR in promoting natural killer cell production of 
IL-10 in vitro and in vivo following infection. NK cells basally expressed the AHR and 
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IL-12 stimulation increased AHR levels in these cells. Inhibition of the AHR led to 
impaired NK cell IL-10 production in vitro, and NK cells isolated from T. gondii-infected 
Ahr-/- mice had defective expression of IL-10. Chapter 3 demonstrates context-dependent 
roles for the AHR during oral and chronic toxoplasmosis. Orally infected Ahr-/- animals 
exhibited more severe weight loss and increased intestinal tissue pathology compared to 
wild-type mice, which was associated with CD4+ T cell hyperactivation. Chronically 
infected Ahr-/- mice developed elevated parasite burdens, but the CD4+ T cell responses in 
these animals were comparable to those in wild-type animals. Collectively these studies 
indicate that the AHR has multiple context dependent roles in the immune response to T. 
gondii. 
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CHAPTER 1: LITERATURE REVIEW 
Introduction 
One of the major challenges faced by the immune system involves mounting an 
inflammatory response to control pathogen growth while limiting immune-mediated 
damage to the host. In order to achieve this balance, responding immune cells need to 
detect signals from the environment and react appropriately by promoting or attenuating 
inflammation. Cells of the immune system employ an array of sensors to respond to 
environmental cues, such as nuclear hormone receptors, cytokine receptors, and Toll-like 
receptors. The aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, 
provides immune cells with an additional means of detecting and responding to 
environmental signals to promote immunity. The work presented in this thesis examines 
the effects of AHR signaling during infection with the protozoan parasite Toxoplasma 
gondii, a medically significant pathogen that naturally infects mice. A variety of AHR 
ligands are produced by the host and the parasite during toxoplasmosis, raising the 
question of whether AHR activity influences the immune response in this setting. Studies 
that were performed to assess the functions of AHR signaling in natural killer cells during 
acute T. gondii infection are described in Chapter 2 of this thesis. Chapter 3 presents 
work examining the role of the AHR in the gut following oral infection with T. gondii, 
and its impact on the chronic phase of toxoplasmosis.  
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Toxoplasma gondii: opportunistic pathogen and model organism 
T. gondii is an intracellular apicomplexan parasite that has the ability to naturally 
infect any warm-blooded vertebrate through an oral route in two infective forms, the 
tissue cyst and the oocyst. Thus, the ingestion of undercooked meat or contaminated 
fruits or vegetables is a major mode of transmission to humans (Jones and Dubey, 2012). 
T. gondii is a widespread and highly successful parasite, which is reflected in infection 
rates as high as 70% in certain regions (Pappas et al., 2009). Human toxoplasmosis 
results in a spectrum of disease, ranging from asymptomatic to severe. In most 
immunocompetent individuals, chronic infection is generally regarded as asymptomatic 
(Montoya and Liesenfeld, 2004). However, the public health importance of 
toxoplasmosis was first recognized in the context of congenital T. gondii infection that 
occurs via maternal-fetal transmission (Wolf et al., 1939). Congenital toxoplasmosis 
results in birth defects such as hydrocephalus, chorioretinitis, and neurological deficits 
(Havelaar et al., 2007), and is estimated to affect up to 4000 births per year in the United 
States (Jones et al., 2001). A second group of patients that are highly susceptible to 
toxoplasmosis consists of individuals with immune-deficiencies including patients with 
AIDS, hyper-IgM syndrome, or those treated with immunosuppressive drugs (Derouin 
and Pelloux, 2008; Israelski et al., 1993; Leiva et al., 1998). The vulnerability of these 
patients highlights the importance of T cells in maintaining protective immunity to T. 
gondii, which will be discussed in more detail in the following sections. As a 
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consequence of these susceptible individuals, infection with T. gondii has been identified 
as a leading cause of food borne mortality in the U.S. (Mead et al., 1999). 
Although toxoplasmosis is generally asymptomatic in patients without immune 
defects, infection with certain strains of T. gondii can cause severe symptoms in 
immunocompetent patients, resulting in ocular disease or death (Demar et al., 2007; 
Grigg et al., 2001). Genetic studies indicate that the structure of the T. gondii population 
in Europe and North America predominantly consists of three clonal lineages, termed 
type I, II, and III (Howe and Sibley, 1995). In other parts of the world, the parasite 
population includes these three strains as well as additional recombinant and exotic 
strains (Boothroyd and Grigg, 2002; Saeij et al., 2005). While type I strains are highly 
virulent and lethal in mice, the type II and type III strains are relatively avirulent 
(Boothroyd and Grigg, 2002). These strain differences are also thought to impact human 
toxoplasmosis, as severe ocular disease in immunocompetent patients is associated with 
type I strains of T. gondii (Boothroyd and Grigg, 2002; Grigg et al., 2001).  
 Although T. gondii can broadly infect warm-blooded vertebrates, domestic and 
wild cats are the definitive hosts for this parasite. Thus, T. gondii sexually reproduces in 
cats, forming highly infectious oocyts that are released into the environment (Elmore et 
al., 2010). Intermediate hosts, in which the parasite replicates asexually, can become 
infected following the ingestion of oocysts. The parasite then converts to a tachyzoite 
form, which replicates and disseminates throughout the host (Dubey et al., 1997). 
Tachyzoites can infect any nucleated host cell through the process of active invasion, 
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which allows the parasite to replicate in a specialized nonfusogenic parasitophorous 
vacuole, eventually leading to host cell lysis and the release of progeny (Sibley, 2011). In 
immunocompetent mice infected with type II or type III strains of T. gondii, the immune 
response leads to the control of the acute phase of parasite growth. The parasite then 
differentiates into a bradyzoite form that replicates slowly and is found in tissue cysts 
located primarily in the brain and muscle tissue (Sibley, 2011). These cysts persist 
chronically, and new hosts can become infected by consuming them (Sibley, 2011; Su et 
al., 2003). Tissue cysts can sporadically reactivate and release tachyzoites, which are 
controlled by the ongoing host immune response, leading to a cycle of reactivation and 
latency that results in life-long infection (Ferguson et al., 1989).   
 Several features of T. gondii make infections with the parasite an effective means 
of studying host-pathogen interactions. T. gondii can readily be cultured in the laboratory 
and is genetically tractable. Additionally, mice are a natural host for the parasite, and 
given the availability of tools to study murine immunity and genetically manipulated 
mouse strains, T. gondii is a useful organism to study the in vivo immune response to 
infection. The pathogenesis of toxoplasmosis, which includes an acute and chronic phase 
and involves parasite replication in multiple tissue sites including the brain and the 
intestines, facilitates the use of this parasite to investigate multiple aspects of immunity to 
infection. Indeed, studies with T. gondii have led to a number of fundamental insights on 
innate immune activation, the generation of Th1 responses, mechanisms of immune 
regulation, and mucosal immunity, which are described in the following sections.  
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Immune reponses to T. gondii 
Innate immunity 
 Following infection, the innate immune system plays a critical role in producing 
the cytokine IL-12, which promotes the development of protective Th1 mediated 
immunity by driving the expression of IFN-γ from innate and adaptive sources  (Figure 
1.1). Consequently, IL-12 depletion renders mice highly susceptible to infection 
(Gazzinelli et al., 1994). In order to initiate anti-parasitic responses, innate immune cells 
need to sense the presence of T. gondii, and multiple studies have addressed the 
mechanisms involved in parasite recognition. Toll-like receptors (TLRs) were implicated 
in this process based on the finding that mice deficient for the TLR adaptor protein 
MyD88 have defects in IL-12 production during infection, develop elevated parasite 
burdens, and succumb to acute toxoplasmosis (Scanga et al., 2002). TLR2, 4, 7, 9, 11, 
and 12 have subsequently been shown to play a role in innate sensing of the parasite. 
TLR2 and TLR4 recognize glycosylphosphatidylinositols found on the surface of T. 
gondii, and mice deficient for both receptors develop increased parasite burdens during 
chronic infection (Debierre-Grockiego et al., 2007). Sensing through TLR7 and TLR9 
induces responses to parasite-derived nucleic acids (Andrade et al., 2013), while TLR11 
and TLR12 recognize a parasite profilin-like molecule (Koblansky et al., 2013; 
Yarovinsky et al., 2005). TLR11 deficient mice concordantly develop higher parasite 
burdens in the chronic phase of infection, whereas mice that lack TLR12 succumb to 
acute infection (Koblansky et al., 2013; Yarovinsky et al., 2005). Notably, there are  
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Figure 1.1: Protective immunity to T. gondii. Innate recognition of T. gondii elicits 
IL-12 production by innate cell populations, which promotes IFN-γ expression by NK 
cells and T cells. IFN-γ signaling induces indoleamine 2,3 dioxygenase, inducible 
nitric oxide synthase, and p47 GTPases, which act to restrict parasite replication. IL-10 
and IL-27 limit the immune response to toxoplasmosis and promote the control of 
immune-mediated pathology.  
 
 
x Control of !parasite growth!
Figure adapted from Hunter, C.A., and L.D. Sibley. 2012. Modulation of innate immunity  
by Toxoplasma gondii virulence effectors. Nature reviews. Microbiology 10:766-778 
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MyD88 independent innate mechanisms of responding to the parasite, as IL-12 
production in response to T. gondii is not completely abrogated in MyD88 deficient cells 
(Scanga et al., 2002). The existence of additional innate recognition pathways was also 
suggested by the finding that mice lacking MyD88 are capable of generating protective 
immunity to rechallenge following immunization with a replication deficient vaccine 
strain of the parasite (Sukhumavasi et al., 2008). One MyD88 independent sensing 
pathway occurs through the recognition of the parasite protein cyclophilin-18 by the 
chemokine receptor CCR5, which promotes IL-12 production by dendritic cells (Aliberti 
et al., 2003). 
Innate recognition of T. gondii elicits the production of IL-12 from neutrophils, 
monocytes, macrophages, and dendritic cells (Goldszmid et al., 2012; Mordue and 
Sibley, 2003; Scanga et al., 2002; Whitmarsh et al., 2011). Dendritic cells, and the 
CD8α+ subset of dendritic cells in particular (Reis e Sousa et al., 1997), serve as a critical 
source of IL-12 during toxoplasmosis, as suggested by the finding that the depletion of 
dendritic cells during infection leads to a profound defect in systemic IL-12 levels and 
mortality (Liu et al., 2006). Additionally, mice that lack expression of the transcription 
factor Batf3, which leads to a loss of CD8α+ dendritic cells, succumb to infection with T. 
gondii but are protected by treatment with recombinant IL-12 (Mashayekhi et al., 2011).  
Natural killer cells, another component of the innate immune system, also respond 
to toxoplasmosis. NK cells from T. gondii infected mice have enhanced cytolytic activity 
against tumor cells and tachyzoites (Hauser and Tsai, 1986), and NK cells exhibit 
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cytotoxicity against cells that have been infected with the parasite (Persson et al., 2009). 
Additionally, NK cells produce IFN-γ during infection, which is induced by IL-12 
signaling (Gazzinelli et al., 1993b). In mice with T cell deficiencies, this IFN-γ 
expression provides a limited degree of protection (Goldszmid et al., 2007; Johnson et al., 
1993) and promotes the priming of CD8+ T cells in CD4 deficient mice (Combe et al., 
2005). Although NK cell IFN-γ is generally not thought to play a critical protective role 
in mice without T cell defects, some studies have indicated that NK cell depletion leads 
to increased mortality during the chronic phase of infection (Goldszmid et al., 2007).  
Adaptive immune responses 
 Some of the earliest studies on immunity to T. gondii focused on the role of B 
cells (Sabin and Feldman, 1948), and humoral immune responses were found to be 
essential during infection. In vitro studies have indicated that antibodies can opsonize T. 
gondii or activate complement mediated parasite lysis (Erbe et al., 1991; Konishi and 
Nakao, 1992; Schreiber and Feldman, 1980; Suzuki and Tsunematsu, 1971; Vercammen 
et al., 1999), suggesting that these processes may be involved in controlling the parasite 
during infection. This role is illustrated by the phenotype of µMT mice, which lack B 
cells, and when challenged with T. gondii develop elevated parasite burdens and succumb 
to infection (Kang et al., 2000). The transfer of parasite-specific antibodies protects B cell 
deficient mice, suggesting that their susceptibility is due to defects in antibody production 
(Kang et al., 2000).  
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Although initial studies on the immune response to toxoplasmosis focused on 
humoral immunity, CD4+ and CD8+ T cell responses are also essential, and for almost 30 
years the role of cell-mediated immunity has been a major area of interest in the field of 
immunoparasitology (Tait and Hunter, 2009). As described in the preceding section, 
innate cells produce IL-12 during infection, and they also present antigen. Together these 
stimuli promote the differentiation of IFN-γ producing effector CD4+ and CD8+ T cells 
(Aliberti et al., 2004; Szabo et al., 2003). Costimulatory molecules also contribute to this 
process, as indicated by the finding that signaling through CD28 and ICOS promotes T 
cell IFN-γ production during toxoplasmosis (Villegas et al., 2002; Wilson et al., 2006). T. 
gondii infection thereby leads to the induction of Th1 polarized CD4+ T cells, which are 
characterized by the expression of IFN-γ and the transcription factor T-bet (Zhu et al., 
2012). Concomitantly with IFN-γ expression, additional functions of CD4+ T cells 
contribute to the establishment of protective immunity. CD4+ T cells activate macrophage 
effector mechanisms through their expression of CD40L (Subauste and Wessendarp, 
2006), and promote the generation of optimal B cell and CD8+ T cell responses (Johnson 
and Sayles, 2002; Lutjen et al., 2006). Consistent with these roles in protective immunity, 
CD4 deficient mice exhibit increased susceptibility to chronic toxoplasmosis (Johnson 
and Sayles, 2002). Like CD4+ T cells, CD8+ T cells produce IFN-γ following infection 
(Shirahata et al., 1994) and additionally exhibit perforin-mediated cytotoxicity that 
promotes the control of parasite burdens (Denkers et al., 1997; Suzuki et al., 2010). 
Consequently, mice that are deficient for CD8 display increased mortality during chronic 
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infection (Denkers et al., 1997; Schaeffer et al., 2009). These findings in mouse models 
are consistent with the increased susceptibility of adult patients with T cell deficiencies to 
toxoplasmosis.  
IFN-γ mediated control of parasite growth 
 IFN-γ plays a critical role in inducing anti-parasitic effector mechanisms during 
infection, and mice in which IFN-γ has been depleted are highly susceptible to T. gondii 
(Suzuki et al., 1988). One of the functions of IFN-γ is to drive the expression of inducible 
nitric oxide synthase (iNOS), which catalyzes the production of nitric oxide. This 
pathway limits in vitro parasite growth in macrophages and microglia (Adams et al., 
1990; Chao et al., 1993; Langermans et al., 1992; Scharton-Kersten et al., 1997). 
Notably, IFN-γ signaling alone is not sufficient to induce optimal levels of nitric oxide 
production, and other stimuli, such as TNF-α, potentiate the expression of this molecule 
during infection (Gazzinelli et al., 1993a; Langermans et al., 1992). An additional effect 
of IFN-γ is to promote the expression indoleamine 2,3 dioxygenase (IDO), which 
catalyzes tryptophan degradation. Since T. gondii is auxotrophic for tryptophan (Sibley et 
al., 1994), IDO activity limits parasite growth in macrophages and other cell types in 
vitro (Gupta et al., 1994; Heseler et al., 2008; Murray et al., 1989; Pfefferkorn et al., 
1986). Critically, IFN-γ also induces the expression of members of the p47 GTPase 
family. Certain p47 GTPases localize to the parasitophorous vacuole and disrupt its 
membrane, which can lead to parasite killing and host cell death by a mechanism that is 
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poorly understood (Hunn et al., 2008; Khaminets et al., 2010; Ling et al., 2006; Martens 
et al., 2005; Zhao et al., 2009).  
In addition to their effects on parasite growth in vitro, iNOS, IDO, and the p47 
GTPases have been implicated in resistance to T. gondii in vivo. Thus, mice that are 
deficient for iNOS do not have a defect in controlling T. gondii replication during the 
acute stage, but exhibit elevated parasite burdens and increased mortality during chronic 
infection (Scharton-Kersten et al., 1997). Mice treated with an IDO inhibitor similarly 
develop elevated parasite burdens and succumb to infection in the chronic phase 
(Divanovic et al., 2012). Additionally, members of the p47 GTPase family contribute to 
immune responses in vivo, as mice deficient for IGTP or LRG-47 have a major defect in 
their ability to control acute parasite replication (Collazo et al., 2001; Taylor et al., 2000). 
In contrast, mice deficient for the p47 GTPase IRG-47 succumb to infection chronically 
(Collazo et al., 2001). The phenotypes of these mice collectively suggest that different 
mediators of IFN-γ-induced resistance to T. gondii contribute to immunity in different 
stages of infection. Accordingly, the expression of iNOS and IDO appear to play an 
important role during chronic toxoplasmosis, while IGTP and LRG-47 are essential in the 
acute control of parasite growth.  
Immune regulation 
 A Th1 immune response characterized by the production of IFN-γ has a critical 
role in controlling T. gondii infection. Importantly, this inflammatory response can also 
cause collateral damage to the host and needs to be appropriately regulated to prevent 
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immune-mediated pathology. The cytokine IL-10 is one of several factors employed by 
the host to limit the immune response during toxoplasmosis. IL-10 is a pleiotropic 
cytokine that has multiple immunosuppressive effects, including the downregulation of 
macrophage cytokine production, the inhibition of costimulatory molecule expression on 
antigen presenting cells, and the promotion of Treg suppressive activity (Chaudhry et al., 
2011; Moore et al., 2001). Notably, IL-10 can also enhance NK cell IFN-γ production 
and promote B cell expansion (Cai et al., 1999; Moore et al., 2001), indicating that this 
cytokine has additional activating effects. The importance of IL-10 during toxoplasmosis 
was revealed in studies with IL-10 deficient mice, which have no defect in controlling 
parasite burdens but produce elevated levels of IL-12 and IFN-γ, develop severe tissue 
pathology and succumb to acute infection (Gazzinelli et al., 1996). Mice given an IL-10 
receptor-blocking antibody during chronic infection also exhibit increased mortality, 
indicating that IL-10 also limits pathological responses chronically (Jankovic et al., 
2007). Similarly, IL-10 deficient mice that have been treated with anti-parasitic drugs that 
allow them to survive acute toxoplasmosis develop lethal inflammation during chronic 
infection (Wilson et al., 2005).   
IL-10 deficient mice in which CD4+ T cells have been depleted are able to survive 
acute toxoplasmosis, indicating that these cells are responsible for the immune-mediated 
damage that occurs in the absence of IL-10 (Gazzinelli et al., 1996). However, CD4+ T 
cells, and IFN-γ producing Th1 cells in particular, are also a critical source of IL-10 
during toxoplasmosis (Jankovic et al., 2007). Mice in which T cells are unable to express 
  
13 
IL-10 consequently die of immune-mediated pathology when challenged with T. gondii 
(Roers et al., 2004). Additionally, mice deficient for both IL-10 and RAG2 that have been 
reconstituted with CD4+ T cells that are capable of producing IL-10 survive T. gondii 
infection while mice given IL-10 deficient CD4+ T cells do not (Jankovic et al., 2007). 
Although CD4+ T cells are an essential source of IL-10 during toxoplasmosis, a number 
of other cell types produce this cytokine, as indicated by the finding that infected IL-10 
deficient SCID mice, which lack B and T cells, exhibit improved survival compared to 
SCID mice (Neyer et al., 1997). These results suggest that innate sources of IL-10 can 
limit protective immunity during toxoplasmosis and have detrimental effects in the 
absence of adaptive immune responses. Subsequent studies have found that NK cells are 
a major early source of IL-10, which is induced by IL-12 signaling (Perona-Wright et al., 
2009). Additional signals that promote IL-10 expression by NK cells are described in 
Chapter 2 of this thesis. NK cell IL-10 has been suggested to limit IL-12 production 
during infection, leading to a negative feedback loop that regulates the expression of IL-
12 (Perona-Wright et al., 2009).  
The cytokine IL-27 is another regulator of immune-mediated pathology following 
infection. Although IL-27 was initially implicated in promoting the development of Th1 
responses, IL-27Rα deficient mice infected with T. gondii produce elevated levels of IL-
12 and IFN-γ and succumb to immune-mediated pathology during toxoplasmosis 
(Villarino et al., 2003). The increased mortality of these mice is rescued by CD4+ T cell 
depletion (Villarino et al., 2003). IL-27 can act directly on CD4+ T cells to promote the 
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expression of IL-10 and inhibit IL-2 production (Stumhofer et al., 2007; Villarino et al., 
2006), which is consistent with its immunoregulatory role during infection. Moreover, 
IL-27 has immunosuppressive effects on innate cell populations, such as dendritic cells 
(Mascanfroni et al., 2013).   
In addition to IL-10 and IL-27, regulatory T cells have been implicated in limiting 
infection-induced pathological responses. Challenge with T. gondii leads to a dramatic 
reduction in Treg numbers in multiple tissues (Oldenhove et al., 2009). This Treg crash 
has been proposed to facilitate the initiation of a protective inflammatory response, but it 
is also associated with increased tissue damage during infection (Benson et al., 2012; 
Oldenhove et al., 2009). Thus, mice that have been treated with IL-2 complexes to 
increase the numbers of Tregs during toxoplasmosis exhibit decreased liver damage 
(Oldenhove et al., 2009). The Treg population also displays phenotypic changes 
following infection, such as increases in the expression of IFN-γ, IL-10, T-bet, and 
CXCR3 (Hall et al., 2012; Oldenhove et al., 2009). T-bet and CXCR3 promote the 
trafficking of Tregs to sites of inflammation (Koch et al., 2009), and are induced in these 
cells by IL-27 (Hall et al., 2012). IL-27 also promotes IL-10 production by Tregs, and the 
effects of IL-27 on these cells may contribute to the infection-induced phenotype of IL-
27Rα deficient mice (Hall et al., 2012). Thus, the effects of IL-27 on IL-10 production 
and Tregs link all three of these immunoregulatory mediators.  
In addition to cytokines, certain lipids also limit the immune response to 
toxoplasmosis. Lipoxin A4, an eicosanoid that interacts with both the formyl peptide 
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receptor-like 1 and the aryl hydrocarbon receptor, inhibits IL-12 production by dendritic 
cells following stimulation with Toxoplasma antigen (Aliberti et al., 2002a; Machado et 
al., 2006). Mice deficient for 5-lipoxygenase, which is required for the synthesis of 
lipoxin A4, develop increased brain inflammation and succumb to toxoplasmosis (Aliberti 
et al., 2002b). Additionally, glucocorticoids limit pathology during infection, as mice that 
lack expression of the glucocorticoid receptor in T cells exhibit signs of increased tissue 
damage and mortality during acute toxoplasmosis (Kugler et al., 2013). This phenotype is 
associated with an elevated frequency of IFN-γ-producing CD4+ T cells in these 
glucocorticoid receptor deficient mice (Jankovic et al., 2010). Collectively these studies 
indicate that multiple mediators orchestrate the immunoregulatory response during 
toxoplasmosis, which is required to prevent lethal immune-mediated damage to the host.  
Mucosal immunity 
 Given the natural oral route of T. gondii infection, the local immune response in 
the gut can be studied upon cyst ingestion. Following oral inoculation, cysts rupture and 
release parasites that infect or invade in between intestinal epithelial cells, leading to 
infection of the small intestinal lamina propria (Barragan et al., 2005; Dubey et al., 1997; 
Speer and Dubey, 1998). T. gondii then invades a variety of cells in this region, including 
macrophages, neutrophils, and T cells (Gregg et al., 2013). Infection results in localized 
areas of intense parasite replication in the small intestine and damage to the epithelium 
(Gregg et al., 2013), with the highest parasite burdens found in the distal portions of the 
small intestine (Dubey et al., 2012). Dissemination of T. gondii may occur through the 
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intestinal lumen (Gregg et al., 2013), or by the transport of the parasite to new sites 
within infected migratory cells (Coombes et al., 2013).  
 In certain mouse strains, including C57Bl/6 mice, oral infection with T. gondii 
leads to ileal inflammation that can be lethal following challenge with a high dose of 
cysts (Dubey et al., 2012; Dubey and Frenkel, 1973; Liesenfeld et al., 1996; McLeod et 
al., 1984). This ileitis is associated with tissue necrosis and the destruction of villi 
(Liesenfeld et al., 1996). CD4+ T cell deficient mice are protected from the development 
of ileal inflammation, indicating that this cell population mediates intestinal pathology 
during toxoplasmosis (Liesenfeld et al., 1996). A number of other factors, including IFN-
γ, TNF-α, nitric oxide, and IL-23 contribute to the development of infection-induced 
ileitis (Liesenfeld et al., 1999; Liesenfeld et al., 1996; Munoz et al., 2009). Recent studies 
have indicated that the intestinal microbiota, which is altered in the course of infection 
(Heimesaat et al., 2006; Molloy et al., 2013), also impacts disease severity. 
Toxoplasmosis leads to disruption of the epithelial barrier and the translocation of 
commensal bacteria to the liver and spleen (Hand et al., 2012). This phenomenon is 
associated with the generation of a commensal-specific T cell response (Hand et al., 
2012). Although the role of these cells during infection is unclear, germ-free mice and 
animals treated with commensal-depleting antibiotics exhibit improved survival and 
reduced ileitis following oral challenge (Heimesaat et al., 2006), suggesting that 
microbiota-specific T cells may promote pathological responses. Additionally, 
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commensal bacteria can act as adjuvants during infection, and promote IL-12 production 
by dendritic cells (Benson et al., 2009). 
 A recently described cell population, termed the group 3 innate lymphoid cell 
(ILC), plays an important role in intestinal immunity and may contribute to the immune 
response during oral toxoplasmosis. ILCs are characterized by their lymphoid 
morphology and lack of rearranged antigen receptors (Spits and Cupedo, 2012). A 
recently proposed system for ILC nomenclature delineated three groups of these cells that 
are analogous to helper T cell subsets (Spits et al., 2013). Thus, group 1 ILCs, which 
include natural killer cells, produce IFN-γ, while group 2 ILCs produce Th2-associated 
cytokines such as IL-5 and IL-13. Group 3 ILCs produce IL-17 or IL-22 and are 
developmentally dependent on RORγt, mirroring Th17 cells (Spits et al., 2013). This 
category can be further subdivided into lymphoid tissue inducer cells, which are essential 
for the development of secondary lymphoid organs, and functionally distinct 
heterogeneous populations of cells designated ILC3s (Spits et al., 2013). Some of these 
ILC subsets exhibit plasticity, and the lineage relationships between them are unclear 
(Walker et al., 2013).  
 Group 3 ILCs have a number of effects on intestinal immunity. These cells 
produce IL-22 at the steady state and limit the dissemination of commensal bacteria that 
normally reside in Peyer’s patches and mesenteric lymph nodes (Sonnenberg et al., 
2012). Group 3 ILCs are also able to present antigen, but lack the expression of 
costimulatory molecules, suggesting that these cells act to limit T cell responses 
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(Hepworth et al., 2013). Accordingly, mice with a RORγt driven deletion of MHC class 
II exhibit increased T cell activation and intestinal inflammation (Hepworth et al., 2013). 
This phenotype is dependent on the presence of commensal bacteria, suggesting that 
ILCs restrict pathological T cell responses against the microbiota (Hepworth et al., 2013). 
In addition to their effects at the steady state, group 3 ILCs play a role during infection 
and intestinal inflammation. Thus, these cells are a critical source of protective IL-22 
following challenge with Citrobacter rodentium (Sonnenberg et al., 2011), and produce 
IL-22 during infection with Candida albicans (De Luca et al., 2010). ILCs have also been 
implicated in promoting the colonic inflammation induced by Helicobacter hepaticus or 
anti-CD40 treatment in RAG deficient mice (Buonocore et al., 2010), and promote the 
ulcerative colitis seen in T-bet deficient RAG deficient animals (Powell et al., 2012). It 
remains unclear whether the functions of group 3 ILCs impact T. gondii infection, but 
data presented in Chapter 3 of this thesis suggest that there are changes in this cell 
population during toxoplasmosis.  
The aryl hydrocarbon receptor and hypoxia inducible factor-1α  
 The preceding sections highlight the importance of mounting a Th1 immune 
response to control infection with T. gondii while appropriately regulating this 
inflammation to prevent immune-mediated pathology. Achieving this balance requires 
immune cells to sense environmental conditions and act accordingly to promote or limit 
the inflammatory response. Signaling through the aryl hydrocarbon receptor represents 
one mechanism that allows cells to detect environmental cues, and experiments that were 
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performed to evaluate how AHR activity influences immunity to T. gondii are presented 
in this thesis.  
The AHR mediates cellular responses to numerous structurally diverse 
compounds including dietary agonists, endogenous molecules, and xenobiotic ligands 
that are byproducts of industrial processes. Notably, there are striking parallels in the 
functions of the AHR and the closely related protein hypoxia inducible factor-1α 
(HIF1α), which is active under low oxygen conditions and allows cells to respond to 
hypoxia. These similarities suggest that insights gained into the immunological roles for 
one pathway might shed light on functions of the other. The following sections provide 
an overview of the physiological roles for the AHR and HIF1α, with a focus on parallels 
between these two pathways.  
Roles in metabolism, cancer, and vascular development 
In addition to their effects on immune responses, signals through the AHR and 
HIF1α have parallel effects on a number of physiological processes. For example, both 
transcription factors have varying effects on metabolism. AHR activation promotes the 
metabolism of xenobiotic compounds by inducing the expression of cytochrome p450 
monooxygenases as well as other enzymes (Hankinson, 1995). HIF1α induces the 
expression of genes involved in glycolysis, allowing cells to switch from oxidative to 
glycolytic metabolism, which promotes adaptation to hypoxic conditions (Seagroves et 
al., 2001). The AHR and HIF1α have perhaps been most extensively studied because of 
their roles in cancer biology. AHR activation can promote tumorigenesis via the 
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induction of enzymes involved in xenobiotic metabolism, which can catalyze the 
production of carcinogenic compounds (Bersten et al., 2013). However, in certain mouse 
models, AHR activity has also been shown to have a tumor suppressor role (Bersten et 
al., 2013). Similarly, HIF1α signaling promotes numerous aspects of carcinogenesis, 
including cell proliferation, changes in metabolism, and angiogenesis, and the expression 
of HIF1α is associated with poor prognosis in many human cancers (Bersten et al., 2013; 
Keith et al., 2012). However, HIF1α can also have tumor suppressor effects in certain 
contexts (Keith et al., 2012).  
Additionally, both the AHR and HIF1α have effects on development in 
invertebrates and mammals. The Drosophila AHR homolog spineless contributes to leg 
and antennae development, as well as the establishment of the retinal mosaic that enables 
color vision (Duncan et al., 1998; Wernet et al., 2006). The Drosophila HIF1α homolog 
Sima promotes the branching of tracheal tubes that distribute oxygen to the tissues 
(Centanin et al., 2008). In mice, AHR deficiency results in vascular abnormalities 
including a patent ductus venosus, which connects the umbilical and portal veins to the 
inferior vena cava (Lahvis et al., 2000). This feature of the fetal circulatory system 
typically closes after birth, but adult AHR deficient (Ahr-/-) mice retain a patent ductus 
venosus (Lahvis et al., 2000; Stevens et al., 2009). AHR deficient embryos also exhibit 
defects in liver perfusion, and additional liver abnormalities are evident in Ahr-/- mice, 
including decreased liver and hepatocyte size, fatty metamorphosis, and portal fibrosis 
(Fernandez-Salguero et al., 1995; Harstad et al., 2006; Lahvis et al., 2000; Schmidt et al., 
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1996). Ahr-/- mice also maintain fetal vascular structures in the eye, and exhibit altered 
kidney vasculature, cardiac hypertrophy, and increased blood pressure (Fernandez-
Salguero et al., 1997; Lahvis et al., 2000; Lund et al., 2003; Thackaberry et al., 2002). 
HIF1α plays a critical role in vascular development, as HIF1α deficiency leads to 
embryonic lethality associated with disorganized vascularization of the yolk sac and 
decreased cephalic vascularization (Iyer et al., 1998; Ryan et al., 1998). This function of 
HIF1α is analogous to the effects of Drosophila Sima on the development of tracheal 
tubes. In light of these findings it has been suggested that the AHR and HIF1α have 
opposing roles in vascular development; the AHR contributes to the pruning of vascular 
structures, which involves removing vessels as the vasculature matures, while HIF1α 
promotes the sprouting of new vessels (Lahvis et al., 2000). Interestingly, the 
developmental roles that have been described for spineless and Sima mirror the functions 
of Drosophila Toll, which was initially characterized for its effects on development but 
was subsequently shown to function in innate immunity (Lemaitre et al., 1996). Indeed, 
in addition to their roles in the interrelated processes of metabolism, tumorigenesis, and 
vascular development, the AHR and HIF1α have a number of similar effects on innate 
and adaptive immunity. The following sections provide an overview of the effects of 
AHR and HIF1α signaling on immune responses to infection, with a focus on parallels 
between these two pathways.  
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Structure and evolution of the AHR and HIF1α 
 The AHR and  HIF1α function as heterodimers and are members of the basic 
helix-loop-helix-PER-ARNT-SIM (bHLH-PAS) superfamily of proteins, which was 
named after its founding members. Both transcription factors are structurally similar, 
with an N-terminal bHLH domain that contributes to dimerization and DNA binding, a 
central PAS domain that also mediates dimerization, and a C-terminal transactivation 
domain that activates transcription following binding to DNA (Kewley et al., 2004; 
Stevens et al., 2009). The PAS sequence is an evolutionarily ancient motif that has been 
identified in proteins expressed by Archaea, Bacteria, and Eucarya (Taylor and Zhulin, 
1999). PAS domains are expressed in a variety of proteins, including photoreceptors, 
circadian clock proteins, chemoreceptors, voltage-gated ion channels, and regulators of 
embryonic development (Taylor and Zhulin, 1999). Proteins containing PAS sequences 
therefore mediate cellular responses to numerous environmental cues and developmental 
signals (Taylor and Zhulin, 1999).  
In contrast to the expression of the PAS motif in all three domains of life, bHLH-
PAS family members are found primarily in metazoans (Sebe-Pedros et al., 2011). 
Phylogenetic studies suggest that the AHR and HIF1α in particular arose from the 
duplication of an ancestral gene following the divergence of sponges but before the 
ancestor to Placozoa, Cnidarians, and Bilaterians (Loenarz et al., 2011; Reitzel et al., 
2014). Accordingly, AHR and HIF1α homologs have not been identified in sponges, but 
are present in some of the simplest metazoans, including placozoans, coral, sea 
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anemones, and nematodes (Hampton-Smith and Peet, 2009; Loenarz et al., 2011; Reitzel 
et al., 2014; Rytkonen and Storz, 2011; Rytkonen et al., 2011; Taylor and McElwain, 
2010). Interestingly, invertebrate AHR homologs do not bind to canonical xenobiotic 
AHR ligands, suggesting that this function for the AHR evolved in chordates (Hahn, 
2002; Reitzel et al., 2014). Although it is unclear whether the AHR affects immunity in 
invertebrates, the HIF1α homolog HIF-1 affects the expression of genes involved in 
Caenorhabditis elegans host defense and mutants with increased HIF-1 activity are more 
susceptible to infection with Staphylococcus aureus (Luhachack et al., 2012). The 
conservation of HIF1α in a broad range of animals that occupy diverse habitats reflects 
the importance of oxygen sensing in the evolution of metazoans, as the maintenance of 
oxygen homeostasis is essential for multicellular organisms that rely on oxygen for the 
process of energy generation (Rytkonen et al., 2011; Semenza, 2007). Thus, the AHR and 
HIF1α are evolutionarily conserved transcription factors with fundamental roles in 
development that also contribute to immune responses.  
Signaling through the AHR and HIF1α 
 Transcriptional activity of the AHR is induced following ligand binding (Figure 
1.2). In the absence of an agonist, the AHR is localized to the cytosol in a complex with 
its chaperone proteins. Upon ligand binding, the AHR complex translocates into the 
nucleus where the AHR interacts with the AHR nuclear translocator (ARNT) to form a 
competent transcription factor. The AHR-ARNT heterodimer binds to dioxin responsive 
elements, and mediates the transcription of a number of different genes (Stevens et al., 
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2009). In addition to its transcriptional effects, the AHR has E3 ubiquitin ligase activity, 
indicating that this transcription factor can also alter intracellular protein levels by 
modulating protein degradation (Ohtake et al., 2007). 
Numerous structurally diverse synthetic and physiologic molecules serve as AHR 
ligands. Classical xenobiotic AHR agonists consist of halogenated aromatic hydrocarbons 
and polycyclic aromatic hydrocarbons, but additional ligands with varying structures 
have been identified (Denison and Nagy, 2003). These molecules include the byproducts 
of industrial processes such as benzo[a]pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(dioxin), the prototypical AHR agonist. Dioxin is a potent toxin whose effects include 
wasting, thymic involution, liver toxicity, porphyria, and carcinogenesis (Poland and 
Knutson, 1982). AHR ligands are also found in cigarette smoke, vehicle exhaust, and 
smoke from burning wood and charcoal, suggesting that airborne molecules could be a 
source of AHR agonists in the lungs and skin (Kasai et al., 2006). Ligands for the AHR 
can also be obtained through the diet, as numerous plant compounds activate this 
transcription factor, making the intestines another major site of exposure to AHR agonists 
(Denison and Nagy, 2003). The effects of the AHR during intestinal infection are 
described in more detail in Chapter 3 of this thesis.  
While there are numerous exogenous sources of AHR ligands, the roles for this 
transcription factor in development suggested that AHR agonists might also be produced 
endogenously. The effects of exposure to certain xenobiotic AHR ligands have been 
studied extensively, but less is understood about the role of endogenous compounds that  
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Figure 1.2: Signaling through the AHR and HIF1α .  
 
In its inactive form, the AHR is localized to the cytosol in a complex with the chaperone 
proteins ARA9, p23, and HSP90. Upon ligand binding, this complex translocates to the 
nucleus where the AHR heterodimerizes with ARNT, forming a competent transcription 
factor that binds to dioxin response elements (DREs).  
 
Under normoxic conditions, HIF1α is hydroxylated by the PHDs, leading to its 
degradation by pVHL. Hypoxia inhibits the activity of the PHDs, leading to the 
stabilization of HIF1α and its translocation into the nucleus. HIF1α then heterodimerizes 
with ARNT, forming a transcription factor that binds to hypoxia response elements 
(HREs).  
 
 
Figure created by Deborah Argento 
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can activate the AHR. In the skin, the high affinity AHR ligand 6-formylindolo[2,3-
b]carbazole (FICZ) is thought to form from tryptophan following stimulation with 
ultraviolet light (Fritsche et al., 2007; Rannug et al., 1995; Wincent et al., 2009). 
Molecules produced during the host response to infection, such as L-kynurenine, can also 
serve as AHR ligands. L-kynurenine is one of the products of IDO induced tryptophan 
degradation, and notably, this compound has been detected in the serum, brain, and other 
tissues following infection with T. gondii (Notarangelo et al., 2014; Silva et al., 2002). 
Additionally, microorganisms can produce AHR ligands. For example, gut resident 
commensal bacteria can synthesize AHR agonists (Zelante et al., 2013). Compounds that 
activate the AHR are also generated by Malassezia yeasts, and have been found in 
diseased human skin (Gaitanis et al., 2008; Magiatis et al., 2013; Vlachos et al., 2012). 
Moreover, extracts from the parasite Toxoplasma gondii contain peptides resembling 
plant lipoxygenases that may allow T. gondii to catalyze the production of lipoxin A4 
(Bannenberg et al., 2004), an AHR ligand that can also be produced by the host (Denison 
and Nagy, 2003). Given the multiple sources of AHR agonists, signaling through this 
transcription factor may be a way of sensing environmental and dietary molecules as well 
as ligands produced by pathogens or the host in response to infection.  
HIF1α is transcriptionally active in environments with low oxygen (Figure 1.2). 
Under normoxic conditions, oxygen and iron sensitive prolyl hydroxylases (PHDs) 
hydroxylate HIF1α, allowing it to be recognized by an E3 ubiquitin ligase, a complex 
that includes von-Hippel-Lindau protein (pVHL), targeting HIF1α for proteasomal 
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degradation (Greer et al., 2012). VHL is a tumor suppressor, and mutations in this gene 
cause VHL disease, which is characterized by the development of benign and malignant 
tumors in patients (Bader and Hsu, 2012). Under hypoxic conditions, the PHDs, which 
serve as oxygen sensors, are less active, allowing for the stabilization of HIF1α protein. 
This process leads to HIF1α translocation to the nucleus, where like the AHR it binds to 
ARNT and forms a competent transcription factor (Greer et al., 2012). The genes induced 
by HIF1α allow adaptation to hypoxic conditions by increasing erythropoiesis in part 
through the induction of erythropoietin, enhancing angiogenesis via the expression of 
genes such as vascular endothelial growth factor, increasing glucose uptake through the 
induction of glucose transporters, and promoting glycolysis in part by increasing the 
expression of glycolytic enzymes (Semenza, 2009). Notably, HIF1α can also be induced 
through stimulation with cytokines, growth factors, or microbial products, which is 
consistent with a role for this transcription factor in immune responses. 
The epidermis and intestine are thought to be relatively hypoxic, suggesting that 
the effects of HIF1α activity may be particularly significant at these barrier sites 
(Karhausen et al., 2004; Rezvani et al., 2011). Importantly, inflammation is also 
associated with the generation of local hypoxic conditions that are thought to be caused 
by disruptions in blood flow as well as the metabolic demands of inflammatory cells and 
pathogens at sites of infection (Gale and Maxwell, 2010; Nizet and Johnson, 2009). 
Accordingly, challenge with a variety of pathogens leads to the formation of hypoxic 
regions in infected tissues (Araujo et al., 2012; Araujo et al., 2010; Grahl et al., 2011; 
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Heng et al., 2011; Hirota et al., 2010; Peyssonnaux et al., 2005). In order to perform their 
functions, immune cells need to travel through and operate in different environments with 
varying oxygen tensions, such as blood vessels, secondary lymphoid organs, and 
inflamed tissues (Gale and Maxwell, 2010). The activity of HIF1α may play a role in 
allowing cells to adapt to these diverse environments.  
Roles for the AHR and HIF1α in innate immunity  
The previous sections highlight the roles of the AHR and HIF1α in environmental 
sensing that can lead to changes in metabolism, which are recently developed topics of 
interest in the field of immunology. These transcription factors are widely expressed in 
immune cells including hematopoietic stem cells, T cell subsets, macrophages, dendritic 
cells, and NK cells, and affect multiple aspects of innate immunity. One of the functions 
of both the AHR and HIF1α is to modulate cytokine production. Thus, in response to 
LPS, AHR deficient macrophages produce decreased levels of IL-10 and elevated 
amounts of the cytokines IL-6, IL-12, and TNF-α, indicating that the AHR promotes IL-
10 expression but limits the production of other cytokines by these cells (Kimura et al., 
2009). In contrast, mice with a targeted HIF1α deletion in macrophages have impaired 
production of IL-12 and TNF-α following LPS injection in vivo (Peyssonnaux et al., 
2007). Mice with HIF1α deficient macrophages consequently exhibit improved survival 
during LPS-induced sepsis (Peyssonnaux et al., 2007), but Ahr-/- mice are more 
susceptible to this challenge (Kimura et al., 2009). HIF1α also promotes macrophage IL-
1β expression following treatment with LPS (Tannahill et al., 2013). Interestingly, LPS 
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stimulation promotes macrophage expression of both the AHR and HIF1α (Kimura et al., 
2009; Peyssonnaux et al., 2007), raising the question of how opposing signals from these 
two transcription factors are integrated to ultimately determine the cytokine production 
response.  
Signaling through the AHR and HIF1α also affects cytokine production by other 
innate cells. AHR deficient dendritic cells exhibit defects in IL-10 production in response 
to LPS (Nguyen et al., 2010). Stimulation with different AHR ligands has varying effects 
on dendritic cell cytokine production, with some agonists promoting the production of 
IL-6, IL-12, and TNF-α while certain ligands inhibit the expression of these proteins 
(Bankoti et al., 2010b; Benson and Shepherd, 2011; Hwang et al., 2007; Ilchmann et al., 
2012; Quintana et al., 2010; Vlachos et al., 2012; Yeste et al., 2012). Although HIF1α 
does not impact the production of these cytokines by dendritic cells (Kohler et al., 2012), 
HIF1α deficient dendritic cells do exhibit defects in their ability to express type I 
interferons and IL-22 (Kohler et al., 2012; Wobben et al., 2013). Different AHR agonists 
also act to either promote or inhibit the dendritic cell expression of the costimulatory 
molecules CD80 and CD86 (Bankoti et al., 2010a; Bankoti et al., 2010b; Benson and 
Shepherd, 2011; Hauben et al., 2008; Ilchmann et al., 2012; Lee et al., 2007; Simones and 
Shepherd, 2011; Vlachos et al., 2012; Vogel et al., 2008; Vogel et al., 2013), and HIF1α 
promotes the expression of these markers (Jantsch et al., 2008; Spirig et al., 2010). These 
effects of the AHR and HIF1α are consistent with a role for these transcription factors in 
innate sensing. Although it is unclear whether HIF1α activity in dendritic cells has an 
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impact during infection, dioxin treatment impairs the ability of these cells to activate 
antigen specific CD8+ T cells (Jin et al., 2010; Jin et al., 2014). The effects of AHR 
signaling on cytokine production by another population of innate cells, natural killer 
cells, are detailed in Chapter 2 of this thesis.  
The AHR and HIF1α also act to promote antimicrobial effector mechanisms in 
innate cells. Signaling through the AHR enhances dendritic cell expression of IDO 
(Nguyen et al., 2010; Vogel et al., 2008). This AHR-mediated IDO expression has been 
implicated in the ability of dendritic cells to promote Treg differentiation (Nguyen et al., 
2010; Vogel et al., 2008). However, as previously described, IDO can also deprive 
pathogens that are auxotrophic for tryptophan of this essential amino acid, leading to 
antimicrobial effects. In addition to T. gondii, species of Chlamydia and Leishmania are 
tryptophan auxotrophs (Divanovic et al., 2012; Ouellette et al., 2006). AHR activity 
additionally promotes the production of reactive oxygen species by macrophages 
following infection with Listeria monocytogenes, and AHR deficient macrophages are 
impaired in their ability to control bacterial growth. Accordingly, Ahr-/- mice are more 
susceptible to infection with L. monocytogenes and develop elevated bacterial burdens 
(Kimura et al., 2014; Shi et al., 2007). The activity of HIF1α increases macrophage 
phagocytosis under hypoxic conditions (Anand et al., 2007). HIF1α deficient 
macrophages exhibit reduced iNOS expression and NO2- production, which is associated 
with a defect in their ability to kill group A Streptococcus (Peyssonnaux et al., 2005). 
Conversely, VHL deficient macrophages, which express increased levels of HIF1α, have 
  
31 
enhanced killing ability (Peyssonnaux et al., 2005). HIF1α also promotes the production 
of antimicrobial peptides by neutrophils, and accordingly, mice with a myeloid cell 
specific deletion of HIF1α develop increased bacterial burdens and larger lesions 
following infection with group A Streptococcus (Peyssonnaux et al., 2005). These studies 
indicate that the AHR and HIF1α can promote a number of pathways in innate cell 
populations that act to limit pathogen growth.   
In addition to its roles in inducing cytokine production and antimicrobial effector 
mechanisms, HIF1α has critical effects on the metabolism and survival of innate cells. 
Macrophages and neutrophils rely heavily on glycolysis to generate ATP, and HIF1α 
contributes to the glycolytic ability of these cells (Cramer et al., 2003). Thus, HIF1α 
deficient macrophages and neutrophils contain decreased levels of ATP even in normoxic 
conditions (Cramer et al., 2003). This metabolic defect is associated with impairments in 
macrophage migration and invasive ability as well as decreased inflammatory responses 
in vivo in mice with a myeloid cell deletion of HIF1α (Cramer et al., 2003). HIF1α also 
promotes neutrophil survival under hypoxia, and concordantly, neutrophils from VHL 
patients exhibit decreased apoptosis (Walmsley et al., 2006; Walmsley et al., 2005). It is 
unclear whether the metabolic effects of AHR signaling influence innate cell function. 
However, this transcription factor has been suggested to protect against macrophage cell 
death during infection by inducing expression of the apoptosis inhibitor of macrophages 
(Kimura et al., 2014), a secreted protein that promotes resistance to cell death (Miyazaki 
et al., 1999).  
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 Effects of AHR and HIF1α signaling on adaptive immunity 
 Like cells of the innate immune system, adaptive immune cells need to function 
in diverse tissue environments to effectively respond to infection, and the AHR and 
HIF1α have a role in allowing these cells to sense and adapt to different settings. Both of 
these transcription factors are most highly expressed in the Th17 subset of CD4+ T cells, 
and promote Th17 differentiation, IL-17 production, and IL-22 expression (Dang et al., 
2011; Kimura et al., 2008; Quintana et al., 2008; Shi et al., 2011; Veldhoen et al., 2008). 
In spite of its effects on Th17 cells, AHR activity does not affect the expression of 
RORγt, the characteristic transcription factor expressed by these cells (Veldhoen et al., 
2009; Veldhoen et al., 2008). In contrast, HIF1α enhances Th17 differentiation in part by 
promoting the transcription of RORγt (Dang et al., 2011). HIF1α may have additional 
effects on Th17 polarization by promoting glycolysis, as inhibiting this process also 
impedes Th17 development (Shi et al., 2011). The significance of AHR and HIF1α 
mediated effects on Th17 cells has been studied most extensively in the context of 
autoimmunity. Thus, Ahr-/- mice or those with a T cell specific deletion of HIF1α are less 
susceptible to experimental autoimmune encephalomyelitis, which is associated with 
decreased Th17 responses (Dang et al., 2011; Shi et al., 2011).  
In addition to their proinflammatory effects on Th17 cells, the AHR and HIF1α 
have been implicated in the induction of regulatory T cell responses, but there are 
conflicting reports on the role of these transcription factors in Tregs. AHR activation by 
particular ligands, such as dioxin or kynurenine, promotes Treg polarization (Mezrich et 
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al., 2010; Quintana et al., 2008), whereas other ligands, such as FICZ, induce Th17 cells 
(Quintana et al., 2008). Although these findings indicate that different AHR agonists can 
mediate varying effects, an additional study found that FICZ and dioxin promote Th17 
cells and Tregs (Kimura et al., 2008). The AHR mediates some of its effects on Tregs by 
binding to the FoxP3 promoter and inducing the expression of this transcription factor 
(Quintana et al., 2008). HIF1α has been shown to similarly promote the expression of 
FoxP3 and the induction of Tregs, and enhance Treg suppressive function (Ben-Shoshan 
et al., 2008; Clambey et al., 2012). However, contrasting studies have indicated that 
HIF1α inhibits Treg generation, possibly by physically interacting with FoxP3 and 
targeting it for degradation (Dang et al., 2011; Shi et al., 2011). The discrepancies in 
these findings suggest that the observed effects of the AHR and HIF1α on Tregs depend 
on experimental conditions.  
The effects of the AHR and HIF1α on T cells influence responses to microbial 
challenge. Thus, AHR activation with dioxin limits the inflammatory damage caused by 
ocular herpes simplex virus infection (Veiga-Parga et al., 2011). This protection is 
associated with decreased cellular infiltration into the cornea and an elevated ratio of 
Tregs to effector T cells due to the increased apoptosis of effector T cells following 
dioxin treatment (Veiga-Parga et al., 2011). In a model of cecal ligation and puncture, T 
cell specific deletion of HIF1α leads to the increased production of IFN-γ by CD8+ T 
cells, elevated expression of TNF-α and IL-6, decreased bacterial burdens, and improved 
survival (Thiel et al., 2007). Similarly, mice with a T cell targeted knockdown of a 
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HIF1α isoform display increased proinflammatory cytokine production and decreased IL-
10 expression following cecal ligation and puncture, which is associated with improved 
survival and decreased bacterial loads (Georgiev et al., 2013). These studies indicate that 
the activity of the AHR and HIF1α can suppress T cell responses during infection.  
In addition to its role in acute responses, HIF1α has effects during chronic 
infection. In mice infected with LMCV clone 13, enhanced HIF1α activity due to a T cell 
specific VHL deletion leads to increased susceptibility to infection as a result of CD8+ T 
cell induced immunopathology (Doedens et al., 2013). VHL deficient T cells exhibit 
resistance to exhaustion, and produce elevated levels of IFN-γ and TNF-α three weeks 
post-infection (Doedens et al., 2013). Additional studies are needed to determine whether 
the AHR has a similar role in T cell responses to chronic infection. However, during 
toxoplasmosis, infected Ahr-/- mice were shown to have decreased parasite burdens and 
increased levels of serum TNF-α (Sanchez et al., 2010). Although the role of T cells in 
this phenotype is unclear, these effects are consistent with a role for the AHR in limiting 
immune-mediated pathology in this setting. Studies that were performed to further 
evaluate the role of the AHR during chronic toxoplasmosis are described in Chapter 3 of 
this thesis.  
The AHR and HIF1α also have effects on B cells, and AHR deficient chimeric 
mice exhibit defects in B cell development (Thurmond et al., 2000). Conversely, 
treatment with AHR ligands such as dioxin has suppressive effects on B cell development 
and inhibits antibody production (Schneider et al., 2009; Sherr and Monti, 2013; Yoshida 
  
35 
et al., 2012). Thus, following challenge with influenza, mice treated with dioxin produce 
decreased levels of virus-specific IgG, and elevated amounts of IgA (Lawrence and 
Vorderstrasse, 2004). HIF1α has also been implicated in B cell development, as HIF1α 
deficient chimeric mice display abnormalities in B cell populations and increased 
production of autoantibodies (Kojima et al., 2002). Additional studies are needed to 
assess the extent to which the effects of the AHR and HIF1α on B cells influence the 
development of protective immunity to infection or immunization.  
Roles for the AHR and HIF1α at barrier surfaces 
The sections above highlight that the AHR and HIF1α have a number of effects 
on the innate and adaptive immune system, suggesting important roles for these 
transcription factors at barrier surfaces such as the intestines and skin, which are rich in 
immune cell populations. Studies indicating that aging Ahr-/- mice develop colonic 
inflammation and rectal prolapses associated with Helicobacter hepaticus established that 
the AHR has important effects on intestinal immunity (Fernandez-Salguero et al., 1997). 
Subsequent work has shown that AHR activity affects the maintenance of various 
immune cell populations in the gut. Thus, Ahr-/- mice have a reduction in intestinal 
intraepithelial lymphocytes (Li et al., 2011) and a decreased population of intestinal 
RORγt expressing innate lymphoid cells (ILCs), as well as defects in IL-22 production by 
ILCs (Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012). This reduced ILC population is 
specific to the lamina propria, as Ahr-/- mice have normal populations of RORγt+ ILCs in 
other sites, such as the Peyer’s patches (Lee et al., 2012).  
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The AHR dependent alterations in intestinal cell populations have consequences 
during infection and influence the intestinal microbiome. IL-22 elicits the production of 
antimicrobial peptides, and in the small intestine of Ahr-/- mice the expression of these is 
impaired (Qiu et al., 2012). ILCs and IL-22 promote resistance to infection with 
Citrobacter rodentium, and consequently Ahr-/- mice are highly susceptible to infection 
with this enteric pathogen (Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012). In 
addition to its effects on bacterial infection, AHR activity in the intestine impacts the 
populations of commensal bacteria that inhabit the gut. Although the relative composition 
of the bacterial flora in Ahr-/- mice is similar to wild-type controls when evaluated at the 
phylum level, Ahr-/- mice have elevated bacterial loads in the small intestine (Li et al., 
2011; Qiu et al., 2012). Ahr-/-animals also have increased intestinal levels of Th17 
promoting segmented filamentous bacteria as a result of their defects in IL-22 expression 
(Qiu et al., 2013). This dysbiosis is associated with the increased susceptibility of Ahr-/- 
mice to experimental colitis (Li et al., 2011), and additional studies are needed to 
determine whether these altered commensal populations affect responses to infection. 
Ahr-/- mice have also been shown to develop cecal tumors, but germ free Ahr-/- mice are 
protected from tumor formation and intestinal inflammation, demonstrating that the 
microbiota also contributes to this phenotype (Ikuta et al., 2013).  
Interestingly, mice fed a diet thought to be low in AHR agonists have reduced 
populations of intestinal intraepithelial lymphocytes and ILCs, indicating that the 
maintenance of these populations at the steady state depends on dietary AHR ligands 
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(Kiss et al., 2011; Li et al., 2011). Further investigation is needed to determine whether 
dietary ligands are also essential during infection, when compounds that activate the 
AHR may be produced by other sources. Additionally, vitamin A metabolism represents 
an underexplored pathway through which dietary compounds and AHR signaling may 
impact immune responses in the intestine. A vitamin A metabolite, retinoic acid, affects 
multiple aspects of immunity, including gut homing, Treg and Th17 differentiation, and 
the size of the RORγt+ ILC population in the gut (Spencer and Belkaid, 2012; Spencer et 
al., 2014). Ahr-/- mice and mice treated with dioxin exhibit perturbations in vitamin A 
metabolism (Andreola et al., 1997), suggesting that AHR mediated effects on this 
pathway could impact immune responses.  
HIF1α has a number of effects on intestinal immunity and barrier function. 
Consistent with a role for this transcription factor in promoting the generation of Th17 
cells, mice with a T cell specific deletion of HIF1α have a reduced population of Th17 
cells in the colonic lamina propria and an increased frequency of Tregs (Dang et al., 
2011). Concordantly, these mice develop more severe intestinal inflammation following 
treatment with dextran sodium sulfate (Higashiyama et al., 2012). However, in agreement 
with studies indicating that HIF1α promotes Treg suppressive function, RAG deficient 
mice are more susceptible to colitis induced by the transfer of CD45RBhigh CD4+ T cells 
when they are given HIF1α deficient Tregs (Clambey et al., 2012), suggesting that these 
effects may be context dependent.  
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In addition to its role in T cell responses in the gut, HIF1α has a number of effects 
in the intestinal epithelium. Signaling through this transcription factor in epithelial cells 
promotes the expression of factors that enhance barrier function such as intestinal trefoil 
factor, ectonucleotidases, and mucin (Furuta et al., 2001; Louis et al., 2006; Synnestvedt 
et al., 2002). In mice with a HIF1α deficiency in the intestinal epithelium, these effects 
are associated with impaired intestinal barrier function and increased susceptibility to 
chemically induced colitis (Karhausen et al., 2004). The deletion of VHL in epithelial 
cells conversely protects against colitis (Karhausen et al., 2004). Interestingly, neutrophil 
respiratory burst activity generates hypoxic microenvironments in the intestine, inducing 
HIF1α signaling in intestinal epithelial cells (Campbell et al., 2014). Mice deficient for 
the respiratory burst develop exacerbated experimental colitis, indicating that neutrophil-
induced HIF1α activity is protective in this model (Campbell et al., 2014) and raising the 
question of whether this pathway also plays a role during enteric infection. Notably, 
contrasting studies using a different model of chemically induced colitis found that 
epithelial VHL deficiency in the intestine increases inflammation (Shah et al., 2008).  
Stimulation with intestinal bacteria can also promote the expression of epithelial 
HIF1α (Hartmann et al., 2008; Koury et al., 2004; Mimouna et al., 2011), and the activity 
of this transcription factor plays a role during intestinal infection. Thus, mice with a 
targeted deletion of HIF1α in the intestinal epithelium exhibit increased mortality duirng 
infection with Yersinia enterocolitica (Hartmann et al., 2008). Following exposure to 
Clostridium difficile toxin, these mice also develop increased inflammation and tissue 
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damage characterized by disruption of the epithelial barrier (Hirota et al., 2010). 
Conversely, treatment with a PHD inhibitor, which leads to increased HIF1α levels, 
protects against this challenge (Hirota et al., 2010).  
 HIF1α also has functions in the skin. Mice with a keratinocyte specific deletion of 
HIF1α develop more severe skin lesions following infection with Group A Streptococcus 
and elevated bacterial burdens. This phenotype is associated with decreased expression of 
the antimicrobial peptide cathelicidin by keratinocytes with a knockdown of HIF1α 
(Peyssonnaux et al., 2008). Complementary work has shown that treatment with a HIF1α 
agonist or a pharmacological compound that stabilizes HIF1α leads to increased 
resistance to Staphylococcus aureus (Okumura et al., 2012; Zinkernagel et al., 2008). 
Although it remains unclear whether AHR signaling plays a role during skin infection, 
the AHR has multiple effects at this barrier surface. Thus, chloracne, a condition 
involving the development of pustules, is characteristic of human exposure to dioxin. In 
studies utilizing an animal model of AHR hyperactivation, mice expressing a 
constitutively active form of the AHR in keratinocytes develop inflammatory skin lesions 
and express increased levels of antimicrobial peptides in the skin (Tauchi et al., 2005). 
Conversely, Ahr-/- mice have been shown to develop skin lesions as they age (Fernandez-
Salguero et al., 1997), and these animals have decreased skin intraepithelial lymphocyte 
populations (Li et al., 2011). Taken together these studies show that the AHR and HIF1α 
have multiple effects on immunity in the intestines and the skin, which is consistent with 
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the notion that these are relatively hypoxic tissues that are also major sites of exposure to 
AHR ligands.  
Exploitation of the AHR and HIF1α by pathogens 
 Although the AHR and HIF1α provide the immune system with the ability to 
respond to environmental conditions, these pathways can also be exploited by pathogens. 
The host cell metabolic state may be of particular importance to intracellular pathogens, 
and changes in host metabolism could limit the growth of these microbes through a 
variety of mechanisms. Studies describing the subversion of AHR signaling by 
microorganisms are limited, but treatment with AHR ligands has been shown to promote 
the reactivation of HIV-1 and other viruses in cell culture, indicating that AHR activity 
can promote viral replication (Burleson et al., 1996; Inoue et al., 2012; Murayama et al., 
2002; Ohata et al., 2003). Signaling through HIF1α can have similar effects on the 
propagation of viruses, as HIF1α associates with the HIV-1 long terminal repeat and 
promotes viral gene transcription (Deshmane et al., 2009). Hypoxia also leads to the 
increased transcription of LCMV genes and increased LCMV protein production in a 
HIF1α dependent manner (Tomaskova et al., 2011). Intracellular parasites also take 
advantage of HIF1α activity to promote their growth. This was demonstrated by studies 
with T. gondii showing that this parasite stabilizes HIF1α by decreasing the abundance of 
PHD2 (Wiley et al., 2010). T. gondii growth is impaired in vitro in HIF1α deficient cells, 
and the parasite exhibits defects in division when grown in HIF1α deficient cells under 
hypoxic conditions (Spear et al., 2006). These studies also highlight the importance of 
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considering oxygen concentration as an experimental condition when studying the role of 
HIF1α, which can have more dramatic effects during hypoxia. Infection with Leishmania 
donovani also leads to increased HIF1α activity in a macrophage cell line, and HIF1α 
knockdown in infected cells leads to decreased intracellular L. donovani growth (Singh et 
al., 2012). Pathogens often target and inhibit cellular pathways involved in innate 
recognition to promote their survival. In contrast, these studies demonstrate that the AHR 
and HIF1α, which are employed by the host to respond to the environment during 
infection, can also be utilized by pathogens to enhance their survival and replication. 
However, not all microbes use HIF1α to their advantage, as indicated by studies showing 
that Chlamydia pneumoniae actively degrades HIF1α during later phases of infection, 
which is associated with host cell resistance to apoptosis (Rupp et al., 2007).  
Conclusion 
 Signaling through the AHR allows cells to sense various environmental and 
endogenously produced compounds, and this transcription factor has multiple 
proinflammatory and immunoregulatory effects on immune responses. Notably, AHR 
agonists such as L-kynurenine and lipoxin A4 are generated during infection with T. 
gondii. In order to successfully respond to challenge with this parasite, the immune 
system needs to establish an effective balance between inflammation that controls T. 
gondii growth and regulatory responses that limit immune-mediated pathology. Studies 
that were performed to evaluate how AHR activity contributes to these responses are 
described in the following chapters of this thesis.  
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CHAPTER 2: THE ARYL HYDROCARBON RECEPTOR PROMOTES IL-10 
PRODUCTION BY NATURAL KILLER CELLS 
 
Abstract 
The cytokine IL-10 has an important role in limiting inflammation in many 
settings, including toxoplasmosis. In these studies, an IL-10 reporter mouse was used to 
identify the sources of this cytokine following challenge with Toxoplasma gondii. During 
infection, multiple cell types expressed the IL-10 reporter, but natural killer cells were a 
major early source of this cytokine. These IL-10 reporter+ NK cells expressed high levels 
of the IL-12 target genes T-bet, KLRG1, and IFN-γ, and IL-12 depletion abrogated 
reporter expression. However, IL-12 signaling alone was not sufficient to promote NK 
cell IL-10 and activation of the aryl hydrocarbon receptor (AHR) was also required for 
maximal IL-10 production. NK cells basally expressed the AHR, relevant chaperone 
proteins, and the AHR nuclear translocator (ARNT), which heterodimerizes with the 
AHR to form a competent transcription factor. In vitro studies revealed that IL-12 
stimulation increased NK cell AHR levels and the AHR and ARNT were required for 
optimal production of IL-10. Additionally, NK cells isolated from T. gondii-infected Ahr-
/- mice had impaired expression of IL-10, which was associated with increased resistance 
to this infection. Together, these data identify the AHR as a critical cofactor involved in 
NK cell production of IL-10. 
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Introduction 
 Toxoplasma gondii is an apicomplexan parasite that induces highly Th1 polarized 
immune responses characterized by the production of IL-12 and IFN-γ, which are 
required to control parasite growth (Gazzinelli et al., 1994; Scharton-Kersten et al., 
1996). Appropriate regulation of this Th1 response is critical for surviving infection, as 
illustrated by reports that IL-10-/- mice infected with T. gondii control parasite burdens 
but succumb to immune-mediated pathology (Gazzinelli et al., 1996; Wilson et al., 2005). 
Although CD4+ T cells contribute to this pathology, these cells are also a critical source 
of IL-10 during toxoplasmosis. Consequently, mice in which T cells are unable to express 
IL-10 also develop immune-mediated tissue pathology when challenged with T. gondii 
(Roers et al., 2004). Additionally, IL-10-/- RAG2-/- mice reconstituted with CD4+ T cells 
that are capable of producing IL-10 survive T. gondii infection while their counterparts 
given IL-10-/- CD4+ T cells do not (Jankovic et al., 2007). Although these results indicate 
that CD4+ T cells are an important source of IL-10 that protects against fatal immune-
mediated pathology during toxoplasmosis, a number of other cell types produce IL-10 
during this infection. The biological relevance of innate sources of IL-10 was suggested 
by the finding that IL-10-/- SCID mice, which lack B and T cells, exhibit improved 
survival following T. gondii infection compared to SCID mice (Neyer et al., 1997). 
Recent studies have shown that NK cells can produce IL-10 and are a biologically 
relevant source of this cytokine during toxoplasmosis (Perona-Wright et al., 2009). NK 
cells are also a source of IL-10 in other murine models of infection, as NK cell IL-10 
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promotes increased parasite burdens during visceral leishmaniasis and limits the 
magnitude of the CD8+ T cell response during murine cytomegalovirus infection (Lee et 
al., 2009; Maroof et al., 2008; Perona-Wright et al., 2009). Together, these reports 
indicate major biological functions for NK cell derived IL-10 in a variety of viral, 
bacterial, and parasitic infections.  
 Recent studies have identified effects of aryl hydrocarbon receptor (AHR) 
signaling on multiple aspects of the immune response, including IL-10 production 
(Apetoh et al., 2010). The AHR is a ligand-activated transcription factor that interacts 
with a structurally diverse array of ligands, comprising synthetic compounds such as 
2,3,7,8-tetrachlorodibenzo-p-dioxin and endogenous molecules, which include certain 
tryptophan and arachidonic acid metabolites (Denison and Nagy, 2003). AHR activity 
was initially studied for its role in mediating tetrachlorodibenzo-p-dioxin-induced 
toxicity. However a number of recent studies have identified multiple effects of AHR 
signaling on the immune system, most notably in Th17 cells and innate lymphoid cells 
(Kimura et al., 2008; Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012; Quintana et al., 
2008; Stockinger et al., 2009). In contrast to its effects in promoting the expression of the 
effector cytokines IL-22 or IL-17 in these cells, the AHR has also been shown to promote 
the production of IL-10. Thus, in type 1 regulatory T cells, the AHR interacts with the 
transcription factor c-Maf to promote IL-10 expression (Apetoh et al., 2010). Ahr-/- 
dendritic cells and macrophages also exhibit defects in IL-10 production (Kimura et al., 
2009; Nguyen et al., 2010). Importantly, AHR activity appears to play a role in the 
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response to T. gondii, as Ahr-/- mice show increased susceptibility to this challenge, 
possibly due to immune-mediated pathology (Sanchez et al., 2010). 
 The studies presented here utilize an IL-10 reporter mouse to characterize the cell 
types that express IL-10 during toxoplasmosis and identified NK cells as a major source 
of this regulatory factor. During acute infection, NK cells that expressed the IL-10 
reporter had higher levels of the IL-12 target genes IFN-γ, T-bet, and KLRG1 than 
reporter negative NK cells and IL-12 depletion abrogated NK cell IL-10 reporter 
expression. However, in vitro studies using NK cells suggested that IL-12 was not 
sufficient to induce IL-10 and that AHR activation contributed to optimal IL-10 
production. NK cells basally expressed Ahr transcripts and these were increased 
following stimulation with IL-12. IL-10 production by in vitro expanded NK cells 
(lymphokine activated killer cells, or LAKs) was enhanced by augmenting AHR activity 
and decreased in the presence of AHR inhibitors. LAKs genetically deficient for the AHR 
or the AHR nuclear translocator (ARNT), which dimerizes with the AHR to form a 
competent transcription factor, were impaired in their ability to produce IL-10. Finally, 
NK cells isolated from Ahr-/- mice that had been infected with T. gondii exhibited defects 
in IL-10 expression. These data identify the AHR as a critical cofactor involved in the 
ability of IL-12 to promote NK cell production of IL-10, suggesting that AHR ligands 
can serve as signals that allow NK cells to sense and respond to their environment. 
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Materials and Methods 
Mice and infections  
Vert-X mice were provided by Dr. Christopher L. Karp (previously at the University of 
Cincinnati College of Medicine, Cincinnati, OH). Ahr-/- mice that had been backcrossed 
onto a C57BL/6J background for 21 generations were obtained from Dr. Christopher A. 
Bradfield (University of Wisconsin School of Medicine and Public Health, Madison, 
WI). Tissues from Vav-Cre Arntfl/fl mice and control mice were provided by M. Celeste 
Simon (University of Pennsylvania, Philadelphia, PA). RAG1-/- mice and C57BL/6J mice 
were purchased from the Jackson Laboratory (Bar Harbor, ME). CBA/J mice were 
purchased from the National Cancer Institute Animal Production Program (Frederick, 
MD). All mice were bred and housed in specific pathogen-free facilities at the University 
of Pennsylvania in accordance with institutional guidelines. For infections, Me49 cysts 
were harvested from the brains of chronically infected CBA/J mice and experimental 
animals were injected i.p. with 20 cysts. For IL-12 depletion, mice were injected i.p. with 
1mg anti-IL-12p40 (clone C17.8) or control rat IgG  (Sigma, St. Louis, MO) one day 
before infection and 3 days post-infection.  
Cell isolation  
Lymphocytes were isolated from the liver as described previously (John et al., 2009). 
Spleens were dissociated through a 40µm filter and red blood cells were lysed with 
0.86% ammonium chloride (Sigma) in sterile water. PECs (peritoneal exudate cells) were 
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collected by lavaging the peritoneal cavity with 7ml PBS. Bone marrow was isolated by 
flushing femurs and tibias with PBS, followed by red blood cell lysis.  
LAK generation  
For the production of LAKs from RAG1-/- mice, bone marrow cells were plated at 1x106 
cells/ml in 10ml complete RPMI 1640 (10% heat inactivated FCS, 2mM glutamine, 
10U/ml penicillin, 10µg/ml streptomycin, 1mM sodium pyruvate, 1% nonessential amino 
acids, 5x10-5M 2-ME) and 4x103U/ml recombinant human IL-2 (proleukin, Novartis, 
Basel, Switzerland). Cells were fed with IL-2 on days 3 and 5 or days 4 and 6 after 
plating. LAKs were collected and stimulated on day 7.  For the generation of LAKs from 
Vert-X mice, Ahr-/- mice, Vav-Cre Arntfl/fl mice, or controls, NK cells were enriched from 
the bone marrow or spleen using the EasySep mouse NK cell enrichment kit 
(STEMCELL Technologies, Vancouver, Canada). CD3- NK1.1+ cells were sorted on a 
FACSAria (BD Biosciences, San Jose, CA) and cultured for 1 week in complete RPMI 
with recombinant human IL-2.  
Stimulation of LAKs or NK cells isolated from infected mice  
LAKs were harvested and plated at a concentration of 1-2.5x106 cells/ml on 96 well 
plates (BD Biosciences). The cells were cultured in complete RPMI (or complete IMDM 
where indicated). LAKs were stimulated with a concentration of 5ng/ml IL-12 
(eBioscience, San Diego, CA) unless otherwise stated, 2000U/ml proleukin, 30µM CH-
223191 (Calbiochem, Darmstadt, Germany), 0.625µM flavone (Sigma), 0.31µM α-
napthoflavone (Sigma), 300nM FICZ (Enzo Life Sciences, Farmingdale, NY), or DMSO 
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(Sigma) as a vehicle control. After 48 hours, supernatants were collected and levels of IL-
10 or IFN-γ were assayed by ELISA. For analysis of IL-10/GFP expression, cells were 
surface stained and run on a FACSCanto II (BD Biosciences). For analysis of IL-10 
production from NK cells from infected mice, DX5+ NK 1.1+CD3- cells were sorted from 
spleens. The purified NK cells were plated at a concentration of 2x106 cells/ml on 96 well 
plates, stimulated for 48 hours with 50ng/ml PMA and 1µM ionomycin, and cytokine 
levels were measured by ELISA.  
ELISAs  
For IL-10 ELISAs, Immulon 4HBX plates (Thermo Fisher Scientific, Waltham, MA) 
were coated with anti-IL-10 (clone JES5-2A5) (BD Pharmingen San Diego, CA), 
blocked in 5% FBS in PBS, and loaded with samples. Biotinylated anti-IL-10 (clone 
JES5-16E3) was used for detection followed by peroxidase-conjugated streptavidin 
(Jackson ImmunoResearch Laboratories, West Grove, PA), SureBlue (KPL, 
Gaithersburg, MD) and TMB Stop Solution (KPL). For IFN-γ ELISAs, plates were 
coated with anti- IFN-γ (clone AN-18) (eBioscience) and loaded with samples. 
Biotinylated anti- IFN-γ (clone R4-6A2) (eBioscience) was used for detection, followed 
by peroxidase-conjugated streptavidin and ABTS (KPL). For IL-12p40 ELISAs, plates 
were coated with anti-IL-12p40 (clone C17.8), loaded with samples, followed by 
detection using biotinylated anti-IL-12p40 (clone C15.6) and ABTS.  
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RNA preparation and PCR  
To evaluate the expression of the AHR and its chaperone proteins, LAKs were stimulated 
for 6 hours or NK1.1+DX5+ cells were sorted from the spleens of RAG1-/- mice. To 
analyze cytokine expression by NK cells from infected wild-type or Ahr-/- mice, 
DX5+NK1.1+CD3- cells were sorted from liver lymphocyte preparations. All sorting was 
performed on a FACSAria or FACSVantage SE (BD Biosciences). RNA was isolated 
using the RNAeasy Mini Kit (Qiagen, Valencia, CA). Samples were treated with DNAse 
(Promega, Madison, WI), and cDNA was generated using reagents from Invitrogen 
(Grand Island, NY). For RT-PCR analysis, cDNA samples were amplified with SYBR 
Green (Applied Biosystems, Carlsbad, CA) on the 7500 Fast Real-Time PCR System 
(Applied Biosystems). Primers for the AHR and β-actin were purchased from Qiagen. 
Primers for the AHR chaperone proteins and ARNT were generated using Primer 3 and 
obtained from Integrated DNA Technologies (Coralville, IA). The following sequences 
were used for p23 (5’-TGATTCCATGAGGCAGTTGA-3’ and 5’-
AATTTGTTTCCGCCTCCTTT-3’), hsp90 (5’-AAGGCAGAGGCTGACAAGAA-3’ 
and 5’-ACAGCAGCACTGGTGTCATC-3’), Arnt (5’-TGCCTCATCTGGTACTGCTG-
3’ and 5’-GAACATGCTGCTCACTGGAA-3’) and Ara9 (5’-
GCTAGGAGTTGCCGAAACAG-3’ and 5’-GAAAGTGGAACGTGGCCTTA-3’). The 
following sequences were used for IL-10 (5’-ACCTGCTCCACTGCCTTGCT-3’ and 5’-
GGTTGCCAAGCCTTATCGGA-3’), IFN-γ (5’-CTTCTTCAGCAACAGCAAGG-3’ 
and 5’-TGAGCTCATTGAATGCTTGG-3’), and HPRT (5’-
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AACTTTTATGTCCCCGGTTGA-3’ and 5’-GGCTATAAGTTCTTTGCTGACCTG-
3’). Relative gene expression was calculated using the 2-ΔΔCT method (Schmittgen and 
Livak, 2008).  
T cell polarization  
CD4+ T cells were sorted from the spleens and lymph nodes of C57BL/6J mice. Cells 
were cultured in complete IMDM for 4 days on plates coated with 1µg/ml anti-CD3 
(eBioscience), with soluble 1µg/ml anti-CD28 (eBioscience). Th17 cells were cultured 
under previously described conditions (Stumhofer et al., 2006). Th1 cells were stimulated 
with 20ng/ml IL-12 and 10µg/ml anti-IL-4 (clone 11B11).  
IL-12 expression in infected mice  
Serum was collected 5 days post-infection and IL-12p40 levels were assayed by ELISA. 
Splenocytes were cultured at 1x106 cells/ml in complete RPMI with or without 62µg/ml 
soluble Toxoplasma antigen (STAg). Supernatants were collected after 48 hours and IL-
12p40 was detected by ELISA. PECs were incubated with brefeldin A (Sigma) and Golgi 
Stop (BD Biosciences) for 6 hours, surface stained, and fixed with 4% paraformaldehyde 
(Electron Microscopy Sciences, Hatfield, PA). Cells were permeabilized with 0.5% 
saponin (Sigma) and stained for IL-12.  
Antibodies and flow cytometry  
For surface staining, samples were washed in flow cytometry buffer containing 1% BSA 
(Sigma) and 2mM EDTA (Invitrogen) in PBS, Fc blocked with 2.4G2 and normal rat IgG 
(Invitrogen), and stained with monoclonal antibodies. For the detection of IFN-γ 
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expression by NK cells, splenocytes were surface stained and stimulated with PMA and 
ionomycin with brefeldin A (Sigma) for 4 hours. The cells were fixed with 4% 
paraformaldehyde, permeabilized with 0.5% saponin, and stained for IFN-γ. For the 
detection of T-bet and Ki67, cells were surface stained and then stained intracellularly for 
T-bet and Ki67 using the FoxP3/transcription factor staining buffer set (eBioscience). For 
the detection of GFP in fixed cells from Vert-X mice, cells were stained intracellularly 
for GFP using an anti-GFP antibody (eBioscience) followed by staining with a secondary 
antibody (Alexa Fluor 488 conjugated AffiniPure goat anti-rabbit from Jackson 
ImmunoResearch). STAT phosphorylation was assayed by flow cytometry as previously 
described (Hall et al., 2012). NK1.1 FITC, CD8 PeCy7, CD11c PeCy7, CD4 APC, CD3 
APC-eFluor 780, CD69 PerCP Cy5.5, IFN-γ PeCy7, T-bet AF647, KLRG1 APC, IL-
12p40 PE and CD19 eFluor 450 were purchased from eBioscience. CD19 PerCP Cy5.5, 
NK1.1 Pacific Blue, and CD3 Pacific Blue were obtained from BioLegend. CD49b PE 
was purchased from BD Biosciences, and Ki67 AF647 was obtained from BD 
Pharmingen. Samples were run on a FACSCanto II and data was analyzed using Flowjo 
software (Tree Star, Inc., Ashland, OR).  
Parasite burdens  
DNA was isolated from the PECs using the High Pure PCR Template Preparation kit 
(Roche, Indianapolis, IN). Parasite DNA levels were determined by RT-PCR as 
previously described (Silver et al., 2011).  
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Statistical analysis 
Statistical significance was determined using paired or unpaired Student’s t tests, which 
were performed using Prism software (GraphPad software, Inc. La Jolla, CA). For Figure 
3B, 5C, 5H, 5I, 5J and 6I paired t tests were used to determine significance using pooled 
data from multiple experiments. In this analysis, the results from each individual 
experiment were paired. 
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Results 
Characterization of cellular sources of IL-10 during toxoplasmosis 
While CD4+ T cells are an essential source of IL-10 during infection, studies in 
SCID mice have suggested that the production of IL-10 by innate cell populations 
promotes susceptibility to T. gondii (Jankovic et al., 2007; Neyer et al., 1997). To identify 
innate and adaptive sources of IL-10, Vert-X IL-10/GFP reporter mice, which have been 
used previously to assess IL-10 expression (Madan et al., 2009; Murai et al., 2009; 
Perona-Wright et al., 2009), were challenged with the Me49 strain of T. gondii. In 
uninfected mice, IL-10/GFP expression in the spleen was largely restricted to small 
populations of CD4+ T cells and B cells (Figure 2.1A). Five days following infection, 
there was an increase in the populations of CD8+ T cells and CD4-CD8- T cells, which 
may be γδ T cells, that expressed the reporter (Figure 2.1B). However, within the spleen, 
liver and peritoneal exudate cells (PECs), a much higher percentage of NK cells were IL-
10/GFP+ at this timepoint than within any of the other cell populations analyzed (Figure 
2.1B). NK cells also constituted the largest fraction of total IL-10 expressing cells in the 
spleen and liver, which are two of the main sites of mature NK cell localization 
(Huntington et al., 2007) (Figure 2.1C). These results indicated that NK cells are a major 
source of IL-10 during early infection, in agreement with previous findings (Perona-
Wright et al., 2009).  
Further characterization of NK cells in the Vert-X mice revealed that infection led 
to a global increase in CD11c and CD69 expression and that these markers of NK cell  
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Figure 2.1: NK cells are a major source of IL-10 early during infection with T. 
gondii. IL-10/GFP expression by different cell populations in the spleens of Vert-X 
mice that were either uninfected (A) or infected with T. gondii five days prior (B) 
Numbers indicate the mean ± the standard deviation from 3-4 independent 
experiments, with a total of 6-9 mice. (C) The percentages of different cell types 
within the total IL-10/GFP+ population in different tissues (spleen, PECs and liver) of 
infected Vert-X mice, represented as pie graphs. Average percentages were calculated 
from 2-3 independent experiments, with a total of 8-10 mice. Various cell types were 
distinguished based on the expression of surface receptors; NK cells 
(DX5+NK1.1+CD3-CD19-), CD4+ T cells (CD3+CD4+), CD8+ T cells (CD3+CD8+), 
CD4-CD8- T cells (CD3+CD4-CD8-), and B cells (CD19+CD3-). 
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activation were expressed similarly by IL-10/GFP+ and IL-10/GFP- NK cells (Figure 
2.2A) (Karlhofer and Yokoyama, 1991; Vosshenrich et al., 2007). The levels of Ki67, a 
marker of proliferating cells, also increased in IL-10/GFP+ and IL-10/GFP- NK cells from 
infected mice (Figure 2.2B). However, several other markers were differentially 
expressed by IL-10/GFP+ and IL-10/GFP- NK cells. Following PMA/ionomycin 
stimulation, a higher percentage of IL-10/GFP+ NK cells produced IFN-γ than IL-
10/GFP- NK cells (Figure 2.2B, C). Most NK cells in naïve mice stained positive for the 
transcription factor T-bet, but T-bet expression increased following infection (Figure 
2.2B) and IL-10/GFP+ NK cells expressed the highest levels of T-bet (Figure 2.2D). Both 
IL-10/GFP+ and IL-10/GFP- NK cells from infected mice expressed high levels of 
KLRG1, but a significantly higher percentage of IL-10/GFP+ cells were KLRG1+ (Figure 
2.2B, E). The marked increases in NK cell expression of CD69 and CD11c following 
infection indicated that both IL-10/GFP+ and IL-10/GFP- NK cells became activated, but 
IL-10/GFP+ NK cells expressed higher levels of IFN-γ, T-bet, and KLRG1, which are 
targets of IL-12 signaling (Joshi et al., 2007; Wilson et al., 2008).  
IL-12 induces NK cell IL-10 expression 
 The finding that NK cells are a major source of IL-10 in early infection raised the 
question of which signals induce IL-10 expression by this population. Previous work has 
shown that IL-12 promotes NK cell IL-10 production during toxoplasmosis (Perona-
Wright et al., 2009), consistent with the finding that IL-10/GFP+ NK cells expressed high 
levels of IL-12 target genes. To examine the effects of IL-12 signaling on NK cells  
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Figure 2.2: Phenotype of IL-10/GFP+ and IL-10/GFP- NK cells.  (A) Expression of 
CD69 and CD11c on NK cells from naïve and infected Vert-X mice.  Results are 
representative of three independent experiments, with a total of 5 naïve and 11 
infected mice. (B) The expression of Ki67, IFN-γ, and T-bet by total NK cells from 
naïve Vert-X mice and the IL-10/GFP+ or IL-10/GFP- NK cells from infected mice. 
Cells were re-stimulated with PMA/ionomycin to evaluate IFN-γ production. Data are 
representative of 2-3 independent experiments with a total of 8-9 infected mice and 4-
5 naïve mice. (C) The frequency of IL-10/GFP- and IL-10/GFP+ NK cells from 
infected Vert-X mice that produce IFN-γ following PMA/ionomycin restimulation. 
Data are pooled from two experiments with a total of 8 mice. (D) The MFI of T-bet in 
IL-10/GFP- and IL-10/GFP+ NK cells from infected Vert-X mice. Data are pooled 
from three experiments with a total of 9 mice. (E) Frequencies of IL-10/GFP- NK 
cells or IL-10/GFP+ NK cells from infected Vert-X mice that were KLRG1+. Data are 
pooled from three independent experiments with a total of 9 mice. NK cells were 
gated as DX5+ NK 1.1+CD3-CD19- cells. 
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during infection, Vert-X mice were treated with IL-12 depleting antibodies and 
challenged with T. gondii. Depletion of IL-12 in infected Vert-X mice abrogated NK cell 
IL-10 reporter expression (Figure 2.3A), in agreement with previous studies (Perona-
Wright et al., 2009). NK cells in infected control and anti-IL-12p40 treated mice 
upregulated expression of CD69 and CD11c (Figure 2.3B). However IL-12 depletion 
antagonized the infection-induced upregulation of KLRG1 and Ki67 (Figure 2.3C, D, E). 
T-bet MFIs (mean fluorescence intensities) were also reduced following IL-12 depletion 
(Figure 2.3C, F). These results suggested that IL-12 signaling during infection promoted 
NK cell IL-10 expression and proliferation. In agreement with this possibility, infected 
mice that had been treated with IL-12 depleting antibodies had fewer total splenic NK 
cells than infected controls (Figure 2.3G).   
To study the factors that regulate NK cell expression of IL-10 in vitro, IL-2 
activated lymphokine activated killer cells (LAKs) were utilized, which were generated 
as previously described (Cai et al., 1999). To evaluate IL-10 production by these cells, 
LAKs were stimulated with different combinations of cytokines for 48 hours. In the 
absence of stimulation, these cells did not produce detectable levels of IL-10 and 
stimulation with IL-2 or IL-12 alone induced little IL-10 secretion (Figure 2.4A). 
However, when treated with the combination of IL-2 and IL-12, LAKs produced high 
levels of IL-10 and IFN-γ as previously reported (Grant et al., 2008). Similar results were 
observed with NK cells freshly isolated from the spleens of RAG1-/- mice (data not 
shown). IL-23 and IL-27, which are members of the IL-12 family of cytokines, did not  
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Figure 2.3: Phenotype of NK cells following IL-12 depletion during infection. 
Vert-X IL-10 reporter mice were infected with T. gondii for five days and given 
control rat IgG or anti-IL-12p40. NK cells were gated as DX5+ NK1.1+CD3-CD19- 
cells. (A) IL-10/GFP expression by NK cells in the spleens of Vert-X mice that were 
given rat IgG or anti-IL-12p40. Numbers represent the mean ± the standard deviation 
from four independent experiments, with a total of 13-16 mice per group. (B&C) 
Expression of CD69, CD11c, KLRG1, Ki67 and T-bet by NK cells from naïve Vert-X 
mice or infected Vert-X mice that were given rat IgG or anti-IL-12p40. Numbers 
represent the mean ± the standard deviation from 2-4 independent experiments with a 
total of 5 naïve and 13-16 infected mice per group. (D) KLRG1 MFIs of KLRG1+ NK 
cells from infected Vert-X mice given rat IgG or anti-IL-12p40. Data are pooled from 
4 independent experiments. (E) Frequency of Ki67+ NK cells from infected Vert-X 
mice given rat IgG or anti-IL-12p40. Data are pooled from 4 independent experiments. 
(F) T-bet MFIs of NK cells from infected Vert-X mice given rat IgG or anti-IL-12p40. 
Data are pooled from 4 independent experiments. (G) Number of NK cells in the 
spleens of infected mice. Results are pooled from 3 experiments. 
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Figure 2.4: LAKs produce IL-10 when stimulated with IL-12 and IL-2. (A) IL-10 
and IFN-γ production by LAKs, 48 hours after stimulation with varying concentrations 
of IL-12 in the presence or absence of IL-2. Results are representative of three 
independent experiments. (B) IL-10 production by LAKs 48 hours post-stimulation with 
the indicated cytokines. Results are representative of 2-3 independent experiments. (C) 
IL-10/GFP expression by NK cells in the spleens of mice that had been infected for 5 
days with T. gondii. Results are pooled from 4 separate experiments. (D) IL-10 and IFN-
γ production by LAKs that were stimulated with IL-2, IL-12 or a combination of the two 
cytokines in RPMI or IMDM for 48 hours. (*p<0.05 based on a paired Student’s t test 
with 4 independent experiments) All error bars represent standard error.  
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induce IL-10 production from LAKs when used in various combinations with IL-2 or IL-
12 (Figure 2.4B). Additionally, IL-27Rα-/- Vert-X mice exhibited no defect in NK cell 
IL-10 expression following infection with T. gondii (Figure 2.4C).  
LAKs and NK cells express the AHR 
 Although these studies highlighted the critical role of IL-12 in inducing NK cell 
IL-10 expression, optimal cytokine production by NK cells typically requires multiple 
signals. Therefore, additional pathways may have contributed to IL-10 induction in these 
cells. One candidate was signaling by the AHR, which promotes IL-10 production by 
macrophages, dendritic cells, and type 1 regulatory T cells cells (Apetoh et al., 2010; 
Kimura et al., 2009; Nguyen et al., 2010). Indeed, LAKs that had been stimulated with 
IL-2 and IL-12 in the culture medium IMDM, which contains high levels of AHR ligands 
(Veldhoen et al., 2009), secreted significantly more IL-10 than LAKs that were cultured 
in RPMI (Figure 2.4D). The production of IFN-γ was not affected by the type of media 
used (Figure 2.4D). Since this result suggested that AHR signaling promoted IL-10 
production, NK cell expression of the AHR, as well as the p23, hsp90 and ara9 chaperone 
proteins that associate with the AHR, were then evaluated (Figure 2.5A). LAKs basally 
expressed transcripts for the AHR, p23, hsp90, ara9, and ARNT (Figure 2.5A), which 
heterodimerizes with the AHR in the nucleus to form a competent transcription factor. 
While the expression of most AHR chaperone proteins and ARNT was not affected by 
IL-12, this treatment did result in an approximately three-fold increase in AHR mRNA 
within six hours (Figure 2.5A). Transcripts for the AHR, p23, hsp90, ara9 and ARNT  
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Figure 2.5: Expression of the Ahr and AHR related genes in LAKS and NK 
cells. (A) The expression of the Ahr and AHR related genes (p23, Hsp90, Ara9 
and Arnt) in LAKs that were stimulated with IL-2, IL-12 or the combination of 
IL-2 and IL-12 for 6 hours. Sample transcript levels were normalized to the 
expression of the housekeeping gene HPRT, and relative levels are shown using 
the media sample as a calibrator. Graphs show the pooled averages from three 
independent experiments. (*p<0.05 based on a Student’s t test). (B) Ahr and AHR 
related gene (p23, Hsp90, Ara9 and Arnt) expression in NK cells sorted from the 
spleens of RAG1-/- mice and in vitro polarized Th1 or Th17 CD4+ T cells. Sample 
transcript levels were normalized to the expression of the housekeeping gene 
HPRT, and relative levels are shown calibrated to the Th1 sample. Results are 
representative of three similar experiments, and error bars are based on technical 
replicates. All error bars represent standard error. 
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were also detected in NK cells that had been freshly isolated from the spleens of RAG1-/- 
mice (Figure 2.5B). Since Th17 cells express high levels of Ahr mRNA compared to 
other T cell subsets, polarized Th17 and Th1 cells were included in these experiments as 
controls (Kimura et al., 2008; Quintana et al., 2008; Veldhoen et al., 2008). These results 
suggest that NK cells are able to respond to AHR signaling and that their ability to do so 
is enhanced by IL-12 stimulation.  
Effect of AHR signaling on IL-10 and IFN-γ production by LAKs 
 To determine the effects of AHR signaling on NK cell cytokine production, LAKs 
were stimulated with AHR inhibitors in the presence of IL-2 and IL-12 and supernatants 
were assayed for IL-10 and IFN-γ. The effects of these inhibitors on LAK IFN-γ 
expression were variable; two of the inhibitors, flavone and α-napthoflavone, had no 
significant effect on IFN-γ production, while treatment with CH-223191 led to decreased 
IFN-γ secretion (Figure 2.6A). No difference in survival was seen between LAKs treated 
with DMSO as a vehicle control or cells stimulated with CH-223191 (data not shown). 
IFN-γ transcript expression also decreased following stimulation with CH-223191 
(Figure 2.6B). To further investigate the effects of AHR signaling on NK cells, LAKs 
were stimulated in vitro with the high-affinity AHR ligand 6-formylindolo[2,3-
b]carbazole (FICZ), which can form intracellularly from tryptophan following exposure 
to ultraviolet light (Fritsche et al., 2007; Rannug et al., 1995). LAKs stimulated with 
FICZ in the presence of IL-2 and IL-12 produced similar levels of IFN-γ as LAKs treated  
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Figure 2.6: AHR signaling promotes IL-10 production by LAKs.  (A, E) Percent 
inhibition by AHR inhibitors (flavone, α−napthoflavone and CH-223191) of IFN-γ 
and IL-10 production by LAKs that were stimulated with IL-2 and IL-12 compared 
to vehicle control (DMSO) treated cells. The data show the average inhibition from 
at least 3 independent experiments. 
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 (B, F) IFN-γ and IL-10 transcript expression by LAKs stimulated for 6 hours or 27 
hours respectively. Sample transcript levels were normalized based on HPRT 
expression, and calibrated to the IL-2 treated sample. Results are representative of 
three similar experiments, and error bars are based on technical replicates (*p<0.05 
based on a paired Student’s t test). (C, H, I) Cytokine production by LAKs stimulated 
with IL-2 and IL-12 in the presence or absence of AHR ligands for 48 hours (*p<0.05 
based on a paired Student’s t test with 5 separate experiments). (D, J) IFN-γ or IL-10 
production by LAKs generated from Ahr-/- or wild-type mice, 48 hours after 
stimulation with IL-2 and IL-12 (*p<0.05 based on a paired Student’s t test with 3 
independent experiments). (G) IL-10/GFP expression by LAKs generated from Vert-
X mice 48 hours post-stimulation. LAKs from C57BL/6J mice were used as controls 
to gate for IL-10/GFP+ cells. Representative plots from 3 independent experiments are 
shown.  (K) IL-10 production by LAKs generated from a Vav-Cre Arntfl/fl mouse or 
control 48 hours post-stimulation. (*p<0.05 based on pooled data from two separate 
experiments)  
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with the vehicle control (Figure 2.6C). Since possible off-target effects with the use of 
pharmacological agents as AHR agonists or antagonists were a concern, LAKs were 
generated from mice genetically deficient for the AHR and wild-type controls (Figure 
2.6D). Following stimulation with IL-2 and IL-12, Ahr-/- LAKs secreted less IFN-γ than 
LAKs from wild-type mice. This reduction was statistically significant (p<0.02) when 
comparing the pooled percentages of Ahr-/- LAK IL-10 production relative to wild-type 
LAKs from three separate experiments. No survival differences were observed between 
wild-type and Ahr-/- LAKs (data not shown). Together, the results from these studies 
suggest a role for AHR signaling in the production of IFN-γ by LAKs.  
 The effects of AHR signaling on IL-10 production by LAKs were also evaluated. 
All three of the AHR inhibitors significantly reduced LAK IL-10 secretion in response to 
IL-2 and IL-12 (Figure 2.6E). Flavone and α-napthoflavone have been shown to act as 
AHR agonists at high concentrations (Kim et al., 2006) and their effects on IL-10 
expression were concentration dependent, with maximal inhibition of IL-10 seen when 
LAKs were treated with intermediate concentrations of these inhibitors (data not shown). 
Similarly, stimulation with CH-223191, the most effective AHR inhibitor used in these 
studies (Kim et al., 2006), also led to a decrease in the level of IL-10 mRNA expressed 
by LAKs (Figure 2.6F). This was corroborated by using LAKs generated from Vert-X 
mice, which expressed reduced levels of the IL-10 reporter following treatment with CH-
223191 compared to cells treated with the vehicle control (Figure 2.6G). While 
stimulation with the AHR agonist FICZ was not sufficient to induce detectable secretion 
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of IL-10, FICZ treatment led to an increase in the amount of IL-10 expressed by LAKs in 
the presence of IL-2 and IL-12 (Figure 2.6H). Thus, augmenting AHR activity in culture 
promoted cytokine-mediated NK cell production of IL-10. However, stimulation with the 
AHR ligand L-kynurenine did not lead to significant differences in IL-10 production 
(Figure 2.6I), suggesting that various AHR ligands have different effects, in agreement 
with previous studies (Quintana et al., 2008). In order to evaluate LAK IL-10 secretion in 
the complete absence of AHR activity, LAKs were generated from Ahr-/- mice or wild-
type controls. When treated with IL-2 and IL-12, Ahr-/- LAKs exhibited significant 
defects in IL-10 production (Figure 2.6J). To determine whether ARNT activity also 
contributed to NK cell IL-10 expression, LAKs were generated from Vav-Cre Arntfl/fl 
mice, in which ARNT is conditionally deleted in hematopoietic cells. Following 
stimulation with IL-2 and IL-12, ARNT deficient LAKs exhibited impaired IL-10 
production (Figure 2.6K), suggesting that the effects of the AHR on NK cell IL-10 
expression were dependent on its interaction with ARNT. Collectively, these studies 
indicated that AHR activity is required for optimal IL-10 expression by LAKs in 
response to stimulation with IL-2 and IL-12. 
 Possible explanations for the contribution of the AHR to NK cell production of 
IL-10 included reduced IL-12 receptor expression or defective IL-12 signaling in the 
absence of AHR activity. Consistent with this possibility, previous work has indicated 
that the AHR can modulate STAT activation in macrophages and T cells (Kimura et al., 
2009; Kimura et al., 2008). To evaluate a role for the AHR in IL-12 signaling, 
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splenocytes from wild-type or Ahr-/- mice were stimulated in vitro with IL-12 and STAT4 
phosphorylation was examined (Figure 2.7). NK cells from wild-type and Ahr-/- mice had 
similar STAT4 phosphorylation responses following IL-12 treatment, indicating that 
proximal IL-12 receptor signaling was intact in the absence of AHR activity, and defects 
in this pathway were not responsible for the decreased IL-10 production seen in Ahr-/- NK 
cells.  
Role of the AHR in the innate response to T. gondii  
To determine the role of the AHR on NK cell responses in vivo, Ahr-/- mice were 
challenged with T. gondii and their innate immune responses were evaluated. Analysis of 
IL-12 production revealed that infection led to comparable serum levels of IL-12 in wild-
type and Ahr-/- mice (Figure 2.8A). Dendritic cells from these mice also expressed similar 
levels of IL-12 (Figure 2.8B, C), and splenocytes isolated from infected wild-type and 
Ahr-/- mice produced comparable levels of IL-12 upon stimulation with soluble 
Toxoplasma antigen (STAg) (Figure 2.8D), indicating that infected Ahr-/- mice had no 
early defect in IL-12 production. Infected Ahr-/- and wild-type mice also had similar 
numbers of NK cells (Figure 2.8E). These populations expressed comparable levels of 
CD69, CD11c, T-bet, KLRG1, and Ki67 (Figure 2.8F, G). However NK cells isolated 
from Ahr-/- mice had marked reductions in their levels of IL-10 mRNA compared to cells 
from wild-type mice (Figure 2.8H). Ahr-/- NK cells isolated from infected mice were also 
impaired in their ability to secrete IL-10 following stimulation with PMA/ionomycin ex 
vivo (Figure 2.8I). However, no differences were seen in IFN-γ production by wild-type  
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Figure 2.7: No defect in STAT4 phosphorylation in Ahr-/- NK cells following 
stimulation with IL-12. Splenocytes from wild-type or Ahr-/- mice were stimulated 
with IL-12 for 2.5 hours and pSTAT4 was assayed by flow cytometry. Plots are 
gated on NK cells (NK1.1+TCRβ-). Results are representative of two independent 
experiments.  
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Figure 2.8: NK cells from Ahr-/- mice express decreased levels of IL-10.  
Wild-type or Ahr-/- mice were infected for five days with T. gondii. (A) IL-
12p40 levels in the serum of WT or Ahr-/- mice. Pooled data from 3 independent 
experiments are shown. (B, C) IL-12p40 production by dendritic cells in the 
PECs (peritoneal exudate cells) following a 6 hour incubation with brefeldin A 
and Golgi Stop. Dendritic cells were gated as CD3-CD19-NK1.1-CD11c+ cells. 
Data are pooled from three independent experiments. 
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 (D) IL-12p40 secretion by splenocytes from infected mice 48 hours post-incubation 
in media alone or STAg. Pooled data from two experiments are shown. (E) Total 
numbers of NK cells in the spleens of infected WT or Ahr-/- mice. Data are pooled 
from three independent experiments with a total of 10 mice per group. NK cells were 
gated as DX5+ NK 1.1+CD3-CD19- cells. (F) CD69 and CD11c expression by splenic 
NK cells from infected wild-type or Ahr-/- mice. Representative plots from three 
independent experiments are shown. (G) Expression of T-bet, KLRG1, and Ki67 by 
splenic NK cells from infected wild-type or Ahr-/- mice. Numbers represent the mean 
± the standard deviation from three separate experiments with a total of 10 mice per 
group. (H) IL-10 transcript expression by NK cells sorted from the livers of infected 
wild-type or Ahr-/- mice. Data are pooled from two separate experiments. (*p<.05 
from a Student’s t test). (I) Cytokine secretion by NK cells sorted from the spleens of 
infected wild-type or Ahr-/- mice and stimulated ex vivo with PMA and ionomycin for 
48 hours. Results from three independent experiments are shown. (*p<.05 based on a 
paired Student’s t test). (J) Levels of parasite DNA in the PECs five days post-
infection. (*p<0.05 from 3 independent experiments with a total of 7-9 mice per grou-
p)  
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or Ahr-/- mice under these conditions (Figure 2.8I). While IL-10 plays a critical role in 
limiting infection-induced immunopathology, IL-10 signaling can also promote increased 
pathogen burdens by attenuating inflammatory responses and suppressing antimicrobial 
activity. Accordingly, infected Ahr-/- mice had decreased parasite burdens during the 
acute phase of infection (Figure 2.8J). Collectively these results indicate that although T. 
gondii infection induced AHR-independent activation of NK cells, optimal NK cell 
expression of IL-10 was dependent on AHR activity. 
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Discussion 
 Multiple studies have identified effects of AHR signaling on cells of the immune 
system, including Th17 cells, regulatory T cells, γδ T cells, innate lymphoid cells, 
dendritic cells, and macrophages (Kimura et al., 2009; Kimura et al., 2008; Kiss et al., 
2011; Lee et al., 2012; Martin et al., 2009; Nguyen et al., 2010; Qiu et al., 2012; Quintana 
et al., 2008; Quintana et al., 2010; Veldhoen et al., 2008). In many of these instances, 
AHR activity affects cytokine production, but AHR signaling can also affect the survival 
or maintenance of certain immune cell populations (Kiss et al., 2011; Lee et al., 2012; 
Qiu et al., 2012). The studies presented here establish that AHR signaling also influences 
NK cell production of IL-10. NK cells basally expressed Ahr transcripts, and Ahr 
expression in LAKs increased following stimulation with IL-12. AHR signaling in turn 
promoted NK cell IL-10 production in vitro and contributed to their IL-12 dependent 
production of IL-10 during infection with T. gondii. Although previous work has 
suggested that NK cell IL-10 limits IL-12 production during experimental toxoplasmosis 
(Perona-Wright et al., 2009), in the studies presented here Ahr-/- and wild-type mice had 
similar levels of IL-12p40. Importantly Ahr-/- mice also had lower parasite burdens than 
wild-type mice, which likely impacted their IL-12 levels.  
While this chapter has focused on the impact of the AHR on NK cell production 
of IL-10, its effects on IFN-γ expression were variable. Treatment with one of the three 
AHR inhibitors used in these studies led to decreased NK cell IFN-γ production, and Ahr-
/-  LAKs were impaired in their ability to express IFN-γ. In contrast, no defect in IFN-γ 
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production was seen in NK cells isolated from infected Ahr-/- mice following 
restimulation ex vivo, but this result could potentially be due to the effects of treatment 
with PMA/ionomycin, potent stimuli that may override a requirement for AHR signaling. 
Notably, a recent study has shown that the AHR promotes NK cell cytolytic activity and 
IFN-γ production, and that NK cells with deficient AHR activity are impaired in their 
ability to control tumor growth (Shin et al., 2013). Collectively these studies indicate that 
the AHR has a number of important effects on NK cell function in settings of infection 
and cancer. Thus AHR expression likely contributes to the ability of NK cells to sense 
environmental signals. NK cells express a number of receptors that allow them to detect 
external cues, including cytokine receptors and activating and inhibitory receptors 
(Yokoyama et al., 2004). AHR activity may provide these cells with an additional means 
of responding to the environment, in this case, by promoting the production of IL-10. NK 
cells have been shown to produce IL-10 following infection with Y. pestis, Listeria 
monocytogenes, and murine cytomegalovirus (Lee et al., 2009; Perona-Wright et al., 
2009).  Additionally, during visceral leishmaniasis, NK cell IL-10 promotes increased 
parasite burdens (Maroof et al., 2008). Indeed, in the studies presented here, the defect in 
NK cell IL-10 expression in Ahr-/- mice correlated with decreased levels of T. gondii at 
five days post-infection. Thus, it seems likely that AHR signaling affects NK cell 
function during challenge with other pathogens and thereby affects the outcome of 
infection.  
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The finding that only a subset of NK cells expressed IL-10/GFP at five days post-
infection raises the question of what accounted for the differential expression of this 
cytokine. These subsets may reflect variability in AHR expression or access to AHR 
ligands. Alternatively, subsets may be distinguished by differences in cytokine 
responsiveness. NK cells exhibit variable expression of IL-12Rβ2, and those cells 
expressing higher levels of IL-12Rβ2 could be more prone to producing IL-10 in 
response to IL-12 stimulation (Chakir et al., 2000). Interestingly, IL-10/GFP+ NK cells 
also expressed high levels of T-bet and KLRG1, mirroring the phenotype of short-lived 
effector CD8+ T cells, which express higher levels of T-bet and KLRG1 than the CD8+ T 
cells that give rise to long term memory (Joshi et al., 2007).  Several reports have 
indicated that NK cells can also form memory populations (Cooper et al., 2009; O'Leary 
et al., 2006; Paust et al., 2010; Sun et al., 2009), and the expression of T-bet and KLRG1 
may distinguish short-lived and long-lived populations of NK cells, paralleling the 
expression of these markers in different populations of CD8+ T cells.  
 This report also raises the question of what the sources of AHR ligands are that 
affect NK cell function. AHR ligands are present in cell culture medium, which is 
consistent with the finding that LAKs stimulated in IMDM, which contains relatively 
high levels of AHR ligands, produced the highest levels of IL-10. In vivo, AHR ligands 
may be obtained through the diet, as a number of plant compounds are thought to activate 
the AHR. Diets low in AHR ligands have been shown to affect immune activity in the gut 
(Kiss et al., 2011; Li et al., 2011), but dietary AHR ligands may have more systemic 
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effects on the immune response. Alternatively, AHR ligands may be produced by NK 
cells themselves or by other host cells in response to infection. An additional possibility 
is that AHR ligands are produced directly by the parasite during infection. T. gondii can 
catalyze the production of lipoxin A4, a putative AHR ligand that can also be produced 
by host cells (Bannenberg et al., 2004). Another potential source of parasite-derived 
ligands is based on the shikimate pathway, which is a biochemical pathway found in T. 
gondii that provides precursors for the synthesis of a number of aromatic compounds 
(Roberts et al., 2002), which may serve as AHR ligands. The shikimate pathway is active 
in a number of pathogens, including other apicomplexans such as Plasmodium 
falciparum and bacteria such as Mycobacterium tuberculosis (Roberts et al., 2002). The 
generation of potential AHR ligands by T. gondii raises the possibility that the AHR may 
act as a sensor that can detect pathogen-derived metabolic products during infection. 
Indeed, it has been suggested that the innate immune system can distinguish between live 
and dead microbes through the detection of viability-associated pathogen associated 
molecular patterns, such as bacterial mRNA (Sander et al., 2011). By acting through the 
AHR, parasite-derived metabolites could potentially function as another class of 
viability-associated pathogen associated molecular patterns.  
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CHAPTER 3: DIFFERENTIAL EFFECTS OF ARYL HYDROCARBON RECEPTOR 
SIGNALING DURING ORAL AND CHRONIC TOXOPLASMOSIS 
 
Abstract 
 The aryl hydrocarbon receptor is a ligand-activated transcription factor that binds 
to multiple xenobiotic and endogenously produced compounds and has multiple effects 
on the immune response. Recent reports have highlighted roles for the AHR in intestinal 
immunity, but less is known about its functions during enteric infection. Thus, 
experiments were performed to determine the effects of AHR signaling during oral 
infection with the parasite Toxoplasma gondii. Compared to wild-type mice, orally 
infected Ahr-/- animals exhibited more severe weight loss and increased intestinal tissue 
pathology, which was associated with CD4+ T cell hyperactivation. In order to determine 
whether AHR signaling also had effects on T cell activation during chronic 
toxoplasmosis when the parasite is primarily localized to the central nervous system, Ahr-
/- mice were infected intraperitoneally with T. gondii. AHR deficient animals had 
elevated parasite burdens during chronic infection. In contrast to the T cell 
hyperactivation seen following acute oral infection, CD4+ T cell responses in chronically 
infected Ahr-/- mice were comparable to those in wild-type animals. Together, these 
results demonstrate distinct roles for the AHR in tissue specific responses during 
toxoplasmosis.
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Introduction 
 A number of recent studies have shown that signaling through the AHR can 
influence the development of both proinflammatory and regulatory immune responses 
(Lawrence and Vorderstrasse, 2013; Stevens et al., 2009). The AHR is a ligand activated 
transcription factor that binds to various structurally diverse agonists including 
endogenous compounds such as certain tryptophan metabolites and synthetic molecules 
exemplified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (Denison and Nagy, 2003). AHR 
ligands derived from plants can also be obtained through the diet (Denison and Nagy, 
2003), making the intestines a major site of exposure to AHR agonists. Signaling through 
this transcription factor has multiple effects on intestinal immune responses. For 
example, the AHR contributes to the maintenance of intraepithelial lymphocytes and 
group 3 innate lymphoid cells (ILCs) in the small intestine lamina propria, and promotes 
IL-22 production by ILCs (Kiss et al., 2011; Lee et al., 2012; Li et al., 2011; Qiu et al., 
2012). AHR activity is also required for the development of isolated lymphoid follicles 
and cryptopatches in the intestine (Kiss et al., 2011; Lee et al., 2012). Moreover, Ahr-/- 
mice have elevated levels of intestinal segmented filamentous bacteria that promote Th17 
cells, indicating that AHR signaling influences commensal populations in the gut (Qiu et 
al., 2013). 
 In addition to its effects on intestinal immunity, the AHR influences other aspects 
of the immune response. AHR deficiency leads to decreased susceptibility to central 
nervous system inflammation in the experimental autoimmune encephalomyelitis model, 
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which is associated with decreased Th17 responses (Quintana et al., 2008; Veldhoen et 
al., 2008). The AHR also has contrasting immunoregulatory roles, and enhances IL-10 
production by a number of cell types, including macrophages, dendritic cells, and natural 
killer cells (Kimura et al., 2009; Nguyen et al., 2010; Wagage et al., 2014). Similarly, in 
type 1 regulatory T cells, the AHR contributes to the ability of IL-27 to induce IL-10 
production (Apetoh et al., 2010). Taken together, these studies indicate that AHR 
signaling influences the development of immunoregulatory and proinflammatory immune 
responses in the intestine as well as other locations, but its role during infection is not 
well understood.  
Establishing an effective balance between inflammatory responses that control 
pathogen growth and immune-regulation that prevents pathology is essential during 
infection with Toxoplasma gondii. This intracellular parasite induces highly Th1 
polarized immune responses typified by IL-12 and IFN-γ expression. These cytokines are 
critical for controlling parasite replication, as mice deficient for IL-12 or IFN-γ develop 
elevated parasite burdens and rapidly succumb to infection (Gazzinelli et al., 1994; 
Scharton-Kersten et al., 1996). While the development of an inflammatory Th1 immune 
response is essential for controlling parasite growth, this response must be appropriately 
regulated to limit immune-mediated pathology to the host. The importance of immune 
regulation during toxoplasmosis has been highlighted by studies in mice deficient for 
either IL-10 or IL-27 signaling (Gazzinelli et al., 1996; Villarino et al., 2003). Following 
infection, IL-10-/- or IL-27Rα-/- mice have no defects in controlling parasite burdens but 
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nonetheless develop severe tissue damage and die acutely. This pathology is mediated by 
CD4+ T cells, as IL-10-/- or IL-27Rα-/- mice survive acute infection following the 
depletion of this population (Gazzinelli et al., 1996; Villarino et al., 2003). Therefore, 
establishing an effective balance between inflammation that controls pathogen growth 
and a regulatory response that prevents excessive immune-mediated pathology is critical 
during toxoplasmosis and is a common feature of many infections (Couper et al., 2008). 
  Interestingly, AHR ligands such as L-kynurenine and lipoxin A4 are generated 
during T. gondii infection (Bannenberg et al., 2004; Silva et al., 2002), and previously 
published work has suggested that the AHR acts to limit inflammation following 
intraperitoneal (i.p.) challenge with the parasite (Sanchez et al., 2010). Similarly, as 
described in Chapter 2, Ahr-/- mice have reduced parasite burdens during acute i.p. 
infection. Given the multiple roles for the AHR in intestinal immunity, experiments were 
performed to determine the effects of AHR signaling in the gut during toxoplasmosis. 
Compared to wild-type mice, orally infected Ahr-/- animals exhibited more severe weight 
loss and increased intestinal tissue pathology. This phenotype was associated with CD4+ 
T cell hyperactivation and increased IFN-γ production, as well as a decreased population 
of group 3 ILCs in the lamina propria.  
In order to determine whether AHR signaling also had effects on T cell activation 
during chronic toxoplasmosis, when the parasite is primarily localized to the central 
nervous system, Ahr-/- mice were infected i.p. with T. gondii. Unexpectedly, chronically 
infected Ahr-/- mice had modestly increased parasite burdens in the brain, but no defects 
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in CD4+ T cell responses were identified. Thus, additional studies were performed to 
evaluate anti-parasitic activity in the absence of AHR signaling. As noted in Chapter 1, 
the AHR has been implicated in promoting macrophage antimicrobial mechanisms, but 
no defects were observed in the ability of Ahr-/- macrophages to control parasite growth 
in vitro. Collectively these results indicate that following acute intestinal toxoplasmosis 
the AHR limits the CD4+ T cell response, but this transcription factor does not have a 
similar role during the chronic phase of infection.  
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Materials and Methods 
Mice and infections 
 Ahr-/- mice that had been backcrossed onto a C57/Bl6 background for 21 generations 
were obtained from Dr. Christopher A. Bradfield (University of Wisconsin School of 
Medicine and Public Health, Madison, WI). C57/Bl6 mice were purchased from the 
Jackson Laboratory (Bar Harbor, ME). CBA/J mice were purchased from the National 
Cancer Institute Animal Production Program (Frederick, MD). All mice were bred and 
housed in specific pathogen-free facilities at the University of Pennsylvania in 
accordance with institutional guidelines. For infections, Me49 cysts were harvested from 
the brains of chronically infected CBA/J mice and experimental animals were injected 
i.p. with 20 cysts or orally gavaged with 20 cysts. For the analysis of parasite burdens, 
DNA was isolated from tissues using the High Pure PCR Template Preparation kit 
(Roche, Indianapolis, IN). Parasite DNA levels were determined by RT-PCR as 
previously described (Silver et al., 2011). 
Cell isolation 
Spleens, lymph nodes and Peyer’s patches were dissociated through a 40µm filter. Red 
blood cells in the spleens were lysed with 0.86% ammonium chloride (Sigma) in sterile 
water. Mononuclear cells were isolated from the brain and lamina propria lymphocytes 
were isolated from the small intestine as previously described (Hall et al., 2012; Wilson 
et al., 2005). Briefly, for cell isolation from the brain, mice were perfused with cold PBS. 
Brain tissue was passed through an 18-gauge needle and incubated with 
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collagenase/dispase (Roche Diagonstics, Indianapolis, IN) and DNAse (Sigma). The 
tissue was dissociated through a 70µm filter, resuspended in 60% isotonic Percoll 
(Amersham Bioscience, Uppsala, Sweden), and overlaid with 30% Percoll. Mononuclear 
cells were isolated from the interphase layer. For cell isolation from the gut, small 
intestines were cut longitudinally and the contents were washed in RPMI. Epithelial cells 
were stripped with 5mM EDTA and 1mM DTT in RPMI, and the tissue was digested 
with 0.16U/mL Liberase TL (Roche) and 0.05% DNAse. The suspension was passed 
through a 70µm filter, and then passed through a 40µm filter.  
ELISAs  
Cells were cultured at 1-2.5x106 cells/ml in complete RPMI with or without 62µg/ml 
soluble Toxoplasma antigen (STAg). Supernatants were collected after 48 hours and 
cytokines were detected by ELISA. For IL-10 ELISAs, Immulon 4HBX plates (Thermo 
Fisher Scientific, Waltham, MA) were coated with anti-IL-10 (clone JES5-2A5) (BD 
Pharmingen San Diego, CA), blocked in 5% FBS in PBS, and loaded with samples. 
Biotinylated anti-IL-10 (clone JES5-16E3) was used for detection followed by 
peroxidase-conjugated streptavidin (Jackson ImmunoResearch Laboratories, West Grove, 
PA), SureBlue (KPL, Gaithersburg, MD) and TMB Stop Solution (KPL). For IFN-γ 
ELISAs, plates were coated with anti- IFN-γ (clone AN-18) (eBioscience) and loaded 
with samples. Biotinylated anti- IFN-γ (clone R4-6A2) (eBioscience) was used for 
detection, followed by peroxidase-conjugated streptavidin and ABTS (KPL). For IL-
12p40 ELISAs, plates were coated with anti-IL-12p40 (clone C17.8), followed by 
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detection using biotinylated anti-IL-12p40 (clone C15.6). Parasite specific antibody 
levels in the serum were assayed as previously described (Glatman Zaretsky et al., 2012). 
RNA preparation and PCR 
RNA from cells was isolated using the RNAeasy Mini Kit (Qiagen, Valencia, CA). RNA 
was isolated from tissues using Trizol (Invitrogen Grand Island, NY) according to the 
manufacturer’s protocol. Samples were treated with DNAse (Promega, Madison, WI), 
and cDNA was generated using reagents from Invitrogen. For RT-PCR analysis, cDNA 
samples were amplified with SYBR Green (Applied Biosystems, Carlsbad, CA) on the 
7500 Fast Real-Time PCR System (Applied Biosystems). Relative gene expression was 
calculated using the 2-ΔΔCT method (Schmittgen and Livak, 2008).  
Flow cytometry 
For intracellular cytokine staining, cells were incubated with brefeldin A (Sigma) and 
PMA and ionomycin for 4 hours, surface stained, and fixed with 4% paraformaldehyde 
(Electron Microscopy Sciences, Hatfield, PA). Cells were then permeabilized with 0.5% 
saponin (Sigma) and stained for cytokines. For surface staining, samples were washed in 
flow cytometry buffer containing 1% BSA (Sigma) and 2mM EDTA (Invitrogen) in PBS, 
Fc blocked with 2.4G2 and normal rat IgG (Invitrogen), and stained with monoclonal 
antibodies. For the detection of T-bet, FoxP3 and Ki67, cells were surface stained and 
then stained intracellularly for these markers using the FoxP3/transcription factor staining 
buffer set (eBioscience). Samples were run on a FACSCanto II or LSRFortessa and data 
was analyzed using Flowjo software (Tree Star, Inc., Ashland, OR).  
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In vitro macrophage infections  
Bone marrow derived macrophages were generated as previously described (Whitmarsh 
et al., 2011). Cells were harvested and plated at a concentration of 1x106 cells/mL in 
polypropylene tubes, stimulated with IFN-γ and TNF-α for 5 hours, and infected with T. 
gondii tachyzoites. One hour later the cells were spun at a low speed and washed to 
remove extracellular parasites. 24 hours post-infection, cytospins of the macrophages 
were stained using the Hema 3 stain set (Fisher Scientific, Kalamazoo, MI) and parasites 
were counted.  
Statistical analysis  
Statistical significance was determined using unpaired Student’s t tests, which were 
performed using Prism software (GraphPad software, Inc. La Jolla, CA). P values of less 
than 0.05 were considered significant. Error bars in all graphs represent the standard 
deviation.  
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Results 
Increased pathology and T cell activation in orally infected Ahr-/- mice 
 The AHR has been shown to affect multiple aspects of intestinal immune 
responses, raising the question of whether this transcription factor influences immunity to 
a parasitic infection of the gut. To investigate the effects of the AHR during intestinal 
infection, wild-type and Ahr-/- mice were challenged orally with a low dose of T. gondii 
cysts and weight loss was monitored over time to determine disease progression. In wild-
type mice, this dose induces modest tissue pathology and weight loss (Figure 3.1A). In 
contrast, infected Ahr-/- mice lost more weight than their wild-type counterparts (Figure 
3.1A). H&E staining of intestinal tissue sections from Ahr-/- mice revealed increased 
tissue pathology (Figure 3.1B). These animals also had modestly elevated parasite 
burdens in the terminal ileum (Figure 3.1C).  
Since CD4+ T cells contribute to immune-mediated pathology during oral 
toxoplasmosis (Liesenfeld et al., 1996), studies were performed to determine whether an 
excessive T cell response might be responsible for the increased pathology seen in the 
absence of AHR signaling. Infected Ahr-/- mice had increased numbers of CD4+ T cells in 
the lamina propria (Figure 3.2A), but not in other sites such as the spleen. T cell 
activation was also evaluated in the spleen and mesenteric lymph nodes following 
infection. CD4+ T cells in infected Ahr-/- mice expressed higher levels of the Th1 
associated transcription factor T-bet, as well as CXCR3, a T-bet target gene (Figure 3.2B 
and data not shown) (Koch et al., 2009; Lord et al., 2005). The expression of Ki67, a  
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Figure 3.1: Increased susceptibility of Ahr-/- mice to oral infection with T. gondii. 
Ahr-/- mice or wild-type controls were infected orally with 20 Me49 cysts for 9 days. 
(A) Weight loss was monitored at various days post-infection. Data are pooled from 2 
experiments with 6-8 mice per group. (B) H&E staining of small intestinal tissue 
sections. (C) Parasite burdens in the terminal ileum of infected mice was measured by 
RT-PCR. Results are pooled from 2 experiments.  
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marker of proliferating cells, was also elevated in CD4+ T cells in Ahr-/- mice, suggesting 
that an increased proportion of these cells was undergoing proliferation (Figure 3.2B). 
However, the expression of T-bet, CXCR3, and Ki67 by CD4+ T cells was comparable in 
naïve wild-type and Ahr-/- mice (data not shown). Additionally, an elevated percentage of 
CD4+ T cells in infected Ahr-/- mice expressed high levels of CD11a, a component of 
LFA-1 that is associated with antigen-experienced T cells (Figure 3.2C) (Doll et al., 
2013).  
Consistent with the increased activation phenotype of Ahr-/- CD4+ T cells, these 
cells produced elevated levels of IFN-γ following stimulation with PMA/ionomycin 
(Figure 3.3A). However, IFN-γ secretion by wild-type and Ahr-/- cells in response to 
soluble Toxoplasma antigen (STAg) was similar (Figure 3.3B). These results raised the 
possibility that the excessive T cell activation seen in Ahr-/- mice was not due to parasite-
specific T cells but rather cells that were recognizing other antigens available during 
infection. Indeed, previous work has shown that toxoplasmosis leads to disruption of the 
intestinal barrier and the induction of microbiota-specific T cell responses (Hand et al., 
2012). This finding suggests that one explanation for the phenotype in Ahr-/- mice is a 
dysregulated response against commensal bacteria. Although additional experiments are 
needed to evaluate this possibility (see Discussion), when taken together these results 
indicated that the increased susceptibility of Ahr-/- mice to oral toxoplasmosis was due to 
pathology mediated by a dysregulated immune response that was associated with 
increased parasite burdens. 
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Figure 3.2: Increased T cell activation in Ahr-/- mice following oral infection.  
Ahr-/- mice or wild-type controls were infected orally with 20 Me49 cysts for 9 days. 
(A) Numbers of CD4+ T cells isolated from the lamina propria of infected mice. Data 
are pooled from 3 experiments. Plots are gated on FoxP3-CD3+CD4+ cells. (B) 
Expression of T-bet, CXCR3, and Ki67 by CD4+ T cells in the mesenteric lymph 
nodes of infected mice. Results are pooled from 3 separate experiments. (C) 
Percentage of CD62LloCD11ahi CD4+ T cells in mesenteric lymph nodes. Data are 
pooled from 2 separate experiments. Plots are gated on CD3+CD4+ cells. 
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Figure 3.3: IFN-γ  expression in Ahr-/- mice following oral infection.  
Ahr-/- mice or wild-type controls were infected orally with 20 Me49 cysts for 9 days. 
CD4+ T cells were gated as CD3+CD4+ cells. (A) Cytokine production by CD4+ T 
cells following stimulation with PMA/ionomycin. Data are pooled from 2 
experiments. (B) IFN-γ secretion by cells from the lamina propria, mesenteric lymph 
nodes, and spleens of infected mice following restimulation with STAg. Results are 
pooled from 2 separate experiments.  
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AHR signaling can influence Treg development (Kimura et al., 2008; Quintana et 
al., 2008), suggesting that a defective Treg response might have promoted the excessive 
T cell activation seen in Ahr-/- mice. However, Treg frequencies were similar in infected 
wild-type and Ahr-/- mice (Figure 3.4A). Previous work has indicated that the expression 
of T-bet and CXCR3 promote Treg function by allowing these cells to migrate to sites of 
inflammation (Hall et al., 2012; Koch et al., 2009). Analysis of the Treg phenotype 
during infection indicated no defects in the expression of these markers in Ahr-/- animals 
(Figure 3.4B). Additionally, although the AHR has been shown to promote IL-10 
production in a variety of cell types (Apetoh et al., 2010; Kimura et al., 2009; Nguyen et 
al., 2010; Wagage et al., 2014), no major defect in IL-10 production following STAg 
restimulation was observed in orally infected Ahr-/- mice (Figure 3.5). Collectively these 
results suggested that the increased susceptibility of Ahr-/- mice to oral toxoplasmosis was 
due to tissue damage mediated by hyperactivated CD4+ T cells, indicating that signaling 
through the AHR acted to limit T cell activation during infection.  
Group 3 ILC responses during oral toxoplasmosis 
 A prominent phenotype in Ahr-/- mice is their lack of lamina propria group 3 ILCs 
(Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012), raising the question of whether these 
cells were influencing the pathology seen in Ahr-/- mice during oral infection with T. 
gondii. Since a role for group 3 ILCs during toxoplasmosis has not been described, 
experiments were performed to evaluate the phenotype of these cells following infection. 
In these studies, oral challenge with T. gondii led to a decrease in RORγt+ ILC frequency  
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Figure 3.4: Treg phenotype in orally infected Ahr-/- mice. Ahr-/- mice or wild-type 
controls were infected orally with 20 Me49 cysts for 9 days. In the mesenteric lymph 
node and spleen Tregs were gated as CD3+CD4+FoxP3+ cells. In the lamina propria, 
Tregs were gated as live CD45+CD3+CD4+FoxP3+ cells. Results are pooled from 2-3 
separate experiments. (A) Frequency of Tregs in the indicated tissues of wild-type or 
Ahr-/- mice. (B) Expression of T-bet, CXCR3, and Ki67 on Tregs in the spleens of wild-
type or Ahr-/- mice.  
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Figure 3.5: IL-10 expression by cells from orally infected Ahr-/- mice. Ahr-/- mice 
or wild-type controls were infected orally with 20 Me49 cysts for 9 days. IL-10 
secrection by cells isolated from the lamina propria or the spleen following 
restimulation with STAg. Results are pooled from 2 separate experiments with a total 
of 5-7 mice per group.  
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and number in the lamina propria (Figure 3.6A, B). However, the expression of Ki67 
increased, suggesting that an increased frequency of these cells was undergoing 
proliferation (Figure 3.6C). Group 3 ILCs in infected mice also expressed reduced levels 
of RORγt (Figure 3.6D). Previous work has indicated that group 3 ILCs are capable of 
presenting antigen, but lack the expression of costimulatory molecules, and consequently 
act to promote tolerance to commensal antigens (Hepworth et al., 2013). Analysis of the 
expression of MHC class II and the costimulatory molecule CD80 on group 3 ILCs 
indicated that these markers were expressed by an increased frequency of RORγt+ ILCs 
during infection, suggesting that these cells may be able to activate adaptive immune 
responses in this setting (Figure 3.6E). In infected Ahr-/- mice, RORγt+ ILCs were absent 
in the lamina propria but were present in the Peyer’s patches at similar frequencies as in 
wild-type animals, consistent with previous descriptions of naïve Ahr-/- mice (Figure 
3.7A) (Lee et al., 2012). Preliminary studies also indicated that these cells produced IL-
22 in infected wild-type mice, while Ahr-/- RORγt+ ILCs exhibited defects in IL-22 
expression  (Figure 3.7B). Thus, the group 3 ILC defects that have been observed in 
naïve Ahr-/- mice were also evident in these animals during toxoplasmosis.  
A role for the AHR in chronic infection 
 In order to determine whether AHR activity also influenced the response to 
chronic toxoplasmosis, wild-type and Ahr-/- mice were challenged i.p. with T. gondii, 
allowing the mice to progress to chronic infection. This route of infection also minimized  
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Figure 3.6: Phenotype of group 3 ILCs following infection. Wild-type mice were 
infected orally with 20 Me49 cysts for 9 days, and cells were isolated from the 
lamina propria of infected mice or naïve controls. Group 3 ILCs were gated as live 
NK1.1-CD3-CD5-CD11c-B220-CD90.2+RORγt+ cells. Results are pooled from 2-3 
separate experiments. (A) Frequency of group 3 ILCs in the lamina propria. The plots 
on the left are gated on live NK1.1-CD3-CD5-CD11c-B220- cells. (B) Number of 
group 3 ILCs isolated from the lamina propria. (C) Ki67 expression by group 3 ILCs. 
(D) RORγt expression by group 3 ILCs. (E) MHC II and CD80 expression by group 
3 ILCs.  
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Figure 3.7: Group 3 ILCs in infected wild-type and Ahr-/- mice. Wild-type or  
Ahr-/- mice were infected orally with 20 Me49 cysts for 9 days. Group 3 ILCs were 
gated as live NK1.1-CD3-CD5-CD11c-B220-CD90.2+RORγt+ cells. Results are 
pooled from 2-3 separate experiments. (A) Frequency of group 3 ILCs in the lamina 
propria and Peyer’s patches. The plots on the left are gated on live NK1.1-CD3-CD5-
CD11c-B220- cells. Results are pooled from two independent experiments. (B) IL-22 
production by group 3 ILCs following restimulation with PMA/ionomycin. Results 
are based on one experiment with 2-3 mice per group. In the lamina propria, the 
frequency of group 3 ILCs in the IL-22+ gate ranged from approximately 4-9% for 
wild-type mice and was less than 3% for Ahr-/- mice. In the Peyer’s patches, the 
frequency of group 3 ILCs in the IL-22+ gate ranged from approximately 4-8% for 
wild-type mice and was less than 2% for Ahr-/- mice.  
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potential effects of the intestinal microbiota and gut derived AHR ligands. As described 
in Chapter 2, i.p. infected Ahr-/- mice had reduced peritoneal parasite levels at 5 days 
post-infection. However, by 41 days post-challenge, Ahr-/- mice developed elevated brain 
parasite burdens, as measured by their levels of parasite DNA (Figure 3.8A). Brain tissue 
sections from Ahr-/- mice also revealed increased numbers of parasite cysts (Figure 3.8B). 
These results indicated that Ahr-/- mice had a reduced ability to control parasite 
replication in the brain, suggesting that the AHR was acting to promote effector 
mechanisms in this setting.   
Given the T cell hyperactivation seen in orally infected Ahr-/- mice, the phenotype 
of CD4+ T cells in i.p. infected animals was also evaluated. Preliminary studies indicated 
that the prominent CD4+ T cell hyperactivation seen 9 days following oral infection was 
absent in Ahr-/- mice that were infected i.p. for 9 days (Figure 3.9). Similarly, the analysis 
of CD4+ T cells during chronic infection in the brains and spleens of Ahr-/- mice indicated 
that these cells expressed comparable levels of T-bet, CXCR3, and Ki67 to wild-type 
controls (Figure 3.10 and data not shown). Additionally, no differences in Treg frequency 
or phenotype were observed between chronically infected wild-type and Ahr-/- animals 
(Figure 3.11).  
In order to evaluate effector cytokine production during chronic infection, mRNA 
was isolated from brain tissue. RT-PCR analysis demonstrated that Ahr-/- mice expressed 
similar levels of IL-12 and IFN-γ transcripts during chronic toxoplasmosis (Figure 
3.12A). Following stimulation with PMA/ionomycin, CD4+ T cells isolated from the  
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Figure 3.8: Elevated parasite burdens in Ahr-/- mice during chronic 
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Figure 3.9: Similar T cell activation in Ahr-/- mice following i.p infection. Ahr-/- 
mice or wild-type controls were infected i.p. with 20 Me49 cysts for 9 days. Results 
are based on 1 experiment with 2-4 mice per group. CD4+ T cells were gated as 
CD3+CD4+ cells. (A) Expression of T-bet, CXCR3, and Ki67 by CD4+ T cells in the 
spleen. FoxP3-CD4+ T cells in wild-type mice were approximately 56-71% T-bet+, 
59-69% CXCR3+, and 69-76% Ki67+. In Ahr-/- mice, FoxP3-CD4+ T cells were 
approximately 67-71% T-bet+, 64-70% CXCR3+, and 68-77% Ki67+. (B) TNF-α and 
IFN-γ production by CD4+ T cells in peritoneal exudate cells and spleens of infected 
mice following restimulation with PMA and ionomycin. In the spleens of wild-type 
mice, 20-40% of CD4+ T cells stained IFN-γ+, while 35-40% of Ahr-/- CD4+ T cells 
stained IFN-γ+.  
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Figure 3.10: T cell activation in chronically infected Ahr-/- mice. Wild-type or 
Ahr-/- mice were infected i.p. with 20 Me49 cysts for 41 days. Expression of T-
bet, CXCR3, and Ki67 by CD4+ T cells in the spleen. Plots are gated on FoxP3-
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Figure 3.11: Treg phenotype during chronic infection. Ahr-/- mice or wild-type 
controls were infected orally with 20 Me49 cysts for 41 days. Tregs were gated as 
CD3+CD4+FoxP3+ cells. Results are pooled from 2 separate experiments. (A) 
Frequency of Tregs in the indicated tissues of wild-type or Ahr-/- mice. (B) 
Expression of T-bet, CXCR3, and Ki67 on Tregs in the spleens of wild-type or  
Ahr-/- mice.  
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brains of chronically infected Ahr-/- mice produced similar levels of IFN-γ as wild-type 
controls (Figure 3.12B). Additionally, brain mononuclear cells from infected Ahr-/- and 
wild-type mice secreted similar amounts of IL-12p40 and IFN-γ when stimulated with 
STAg (Figure 3.12C). Together, these data revealed that the prevalent T cell 
hyperactivation seen following acute oral infection in Ahr-/- mice was absent following 
i.p. challenge. Additionally, although Ahr-/- mice were impaired in their ability to control 
parasite burdens chronically, no defect in Th1 responses was apparent in these animals.  
Other effector mechanisms in Ahr-/- mice 
 In an attempt to understand the basis for the increased parasite burdens in 
chronically infected Ahr-/- mice, additional effector mechanisms involved in controlling 
T. gondii growth were analyzed. Since humoral immunity plays an essential role in 
controlling parasite burdens (Kang et al., 2000), the production of T. gondii-specific 
antibodies in wild-type and Ahr-/- mice was assayed. No difference was observed in the 
circulating levels of parasite-specific antibodies in Ahr-/- mice (Figure 3.13A). 
Additionally, the activation of innate cell populations, such as microglia, was intact in the 
brains of chronically infected Ahr-/- mice (Figure 3.13C). A possible alternative 
explanation for the increased parasite burdens seen in Ahr-/- mice was a cell intrinsic 
defect in controlling parasite growth. Indeed, previous work has shown that the AHR 
promotes the expression of indoleamine 2,3, dioxygenase in dendritic cells (Nguyen et 
al., 2010). This enzyme catalyzes tryptophan degradation, thereby limiting the growth of 
T. gondii, a tryptophan auxotroph (Divanovic et al., 2012; Pfefferkorn et al., 1986). In 
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order to determine whether Ahr-/- cells had a defect in controlling parasite replication in 
response to cytokine stimulation, bone marrow-derived macrophages from wild-type or 
Ahr-/- mice were stimulated in vitro with IFN-γ and TNF-α. The cells were infected with 
T. gondii tachyzoites, and twenty four hours later, intracellular parasite numbers were 
determined (Figure 3.13D). Wild-type and Ahr-/- macrophages had similar rates of 
infection when left unstimulated or when treated with IFN-γ and TNF-α, indicating that 
macrophages had no defect in controlling parasite growth in the absence of AHR 
signaling. In agreement with these findings, the levels of transcripts in the central nervous 
system for indoleamine 2,3, dioxygenase and IGTP, which are induced by IFN-γ and 
promote the control of parasite growth, were similar between wild-type and Ahr-/- mice 
(Figure 3.13D). Thus, although chronically infected Ahr-/- mice had elevated parasite 
burdens, no defect was apparent in their Th1 immune response or in the cell intrinsic 
ability of Ahr-/- macrophages to limit parasite replication.  
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Figure 3.12: Cytokine expression in Ahr-/- mice during chronic infection.  
Wild-type or Ahr-/- mice were infected i.p. with 20 Me49 cysts for 41 days. (A) The 
mRNA levels of the indicated cytokines in the brains of chronically infected mice were 
assayed by RT-PCR. Results are representative of two experiments. (B) Isolated brain 
mononuclear cells were stimulated with PMA/ionomycin for 4 hours and stained for 
cytokine production. Plots are gated on CD3+CD4+ cells. Data are pooled from 2 
experiments. (C) Isolated brain mononuclear cells were restimulated with STAg for 48 
hours. Supernatants were collected, and cytokine production was assayed by ELISA. 
Data are pooled from 3 separate experiments.  
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Figure 3.13: Antibody production and innate cell activation in Ahr-/- mice.  
(A) Levels of parasite-specific IgG2c in the serum of wild-type or Ahr-/- mice that 
were infected i.p. with 20 Me49 cysts for 41 days. Results are pooled from three 
experiments. (B) Gating for microglia in brain mononuclear cells that were isolated 
from mice that had been infected i.p. for 41 days. Plots are gated on CD3-CD19-
NK1.1-cells. Results are based on three independent experiments. (C) MHC II and 
CD80 expression on microglia 41 days following i.p. infection. Plots are gated as 
shown in figure 3.13B. Results are representative of 3 experiments. (D) Bone marrow-
derived macrophages were stimulated with IFN-γ and TNF-α and infected with T. 
gondii tachyzoites. The cells were stained and parasites were counted 24 hours post-
infection. Results are representative of 5 experiments. (E) The mRNA levels of IGTP 
and IDO in the brains of chronically infected mice were assayed by RT-PCR. Results 
are representative of two experiments.  
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Discussion 
 Collectively these studies indicate that AHR signaling has different roles during 
acute oral toxoplasmosis and chronic infection. Following oral challenge with T. gondii, 
the absence of AHR activity led to increased pathology and CD4+ T cell hyperactivation, 
raising the question of how this transcription factor limits T cell responses in this setting. 
Although the AHR plays a role in T cell IL-10 production and Treg development, which 
constrain the immune response during toxoplasmosis, no deficiencies in these pathways 
were observed in Ahr-/- mice. The group 3 ILC defects seen in infected Ahr-/- mice raised 
the possibility that this phenotype could contribute to the pathology observed in AHR 
deficient animals. In naïve mice, group 3 ILCs and IL-22 signaling limit the 
dissemination of commensal bacteria (Sonnenberg et al., 2012), suggesting that these 
cells may act in a similar capacity during toxoplasmosis. Intestinal T. gondii infection in 
wild-type mice leads to the translocation of gut resident commensal bacteria to other sites 
and the generation of microbiota specific T cell responses (Benson et al., 2009; Hand et 
al., 2012). These findings raised the possibility that the Ahr-/- defect in group 3 ILCs may 
lead to increased bacterial translocation during infection and an elevated immune 
response against the microbiota. This model could be tested by treating Ahr-/- mice with 
antibiotics during toxoplasmosis to deplete commensal bacteria and evaluating whether 
this treatment attenuates the T cell hyperactivation seen in these animals. Additional 
studies with a tetramer that detects T cells specific for an epitope expressed by a group of 
commensal bacteria could determine whether there are increased microbiota-specific T 
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cell responses in Ahr-/- mice. Alternatively, other cell types or pathways may contribute to 
the T cell hyperactivation seen in these animals. For example, inflammatory monocytes 
were recently shown to express IL-10 and prostaglandin E2 and limit pathology during 
infection (Grainger et al., 2013), and the loss of the AHR may lead to reduced production 
of these immunoregulatory mediators in monocytes.  
 Orally infected Ahr-/- mice had modestly elevated parasite burdens, which could 
also contribute to the T cell hyperactivation seen in these animals. Increased levels of T. 
gondii were also observed in the brains of chronically infected Ahr-/- mice. This 
phenotype differs from a previous finding indicating that AHR deficient animals exhibit 
decreased parasite burdens but increased mortality following i.p. infection (Sanchez et 
al., 2010). One factor that might contribute to this discrepancy is the timepoint post-
infection at which parasite burdens were assayed. The previously published work 
described reduced parasite levels in Ahr-/- mice at 25 days post-challenge, and in 
agreement with this, the studies discussed in Chapter 2 identified decreased parasite 
burdens in these animals during early T. gondii infection. However, in multiple 
experiments, Ahr-/- mice had increased parasite levels in the brain 41 days post-challenge. 
These results suggest that the relative T. gondii burdens in Ahr-/- mice increase over time, 
eventually leading to increased parasite levels compared to wild-type animals. As 
discussed in Chapter 2, AHR activity in NK cells may contribute to the decreased 
parasite burdens seen in Ahr-/- mice during acute infection, and NK cell numbers and 
activity decline later in toxoplasmosis (Neyer et al., 1997). Alternatively, this increase in 
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parasite levels may be due to differences in the environment of the central nervous 
system compared to the primary site of infection during acute i.p. challenge. Previous 
work has also shown that Ahr-/- mice generated in different laboratories can have different 
phenotypes following infection (Lawrence and Vorderstrasse, 2013), which may explain 
the variability in these findings. Some of the phenotypic differences in strains of Ahr-/- 
mice have been attributed to the extent to which these mice were backcrossed prior to 
analysis (Esser, 2009). The Ahr-/- mice that were used in these studies had been 
backcrossed onto a C57/Bl6 background for 21 generations (Harstad et al., 2006).   
 No differences were seen in chronic Th1 responses or cell-intrinsic control of T. 
gondii growth in the absence of AHR signaling, but Ahr-/- mice developed elevated 
parasite burdens, raising the question of why these animals have a defect in limiting 
parasite replication. One possibility is that the AHR has cell-type specific effects that 
were not identified in these studies. For example, AHR signaling may control parasite 
replication in neural cells in the central nervous system during chronic infection but not 
in the macrophages that were used for in vitro analysis. Alternatively, functions of the 
AHR in nonhematopoietic cells may impact the outcome of infection, which could be 
addressed through the use of chimeric approaches. For example, the vascular defects in 
Ahr-/- mice could lead to altered dissemination of T. gondii in the brain or the metabolic 
changes induced by AHR activity may influence parasite growth.  
Together, the use of different routes of T. gondii infection highlight context-
dependent roles for the AHR during infection. The effects of the microbiota during 
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intestinal infection offer one possible explanation for the different phenotypes seen in 
orally and i.p. infected Ahr-/- mice. Alternatively, given findings indicating that different 
AHR ligands can have distinct effects, these varying outcomes may be a reflection of the 
different sources of AHR ligands available in discrete sites of infection. AHR agonists 
found in the diet or produced by commensal bacteria are prevalent in the gut, whereas 
compounds produced by the host such as L-kynurenine may be more important in the 
brain. Gaining an understanding of how AHR signaling mediates context-dependent 
effects could facilitate targeting this pathway therapeutically and provide insight into how 
exposure to environmental or infection-induced AHR agonists impacts health.  
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CHAPTER 4: DISCUSSION 
 
Increasing appreciation of AHR-mediated effects on immunity 
 Some of the earliest reports that suggested a role for the AHR in the immune 
system were toxicological studies examining the effects of exposure to synthetic AHR 
agonists such as dioxin. Dioxin treatment has multiple effects on immunity, including 
thymic involution, the inhibition of delayed hypersensitivity responses, and the 
suppression of antibody production (Buu-Hoi et al., 1972; Faith et al., 1978; Tucker et al., 
1986). Concordantly, exposure to low doses of dioxin was found to increase murine 
susceptibility to challenge with Salmonella and Plasmodium yoelli (Thigpen et al., 1975; 
Tucker et al., 1986). These studies need to be interpreted carefully due to the systemic 
toxic effects of dioxin, which make identifying the specific mechanisms for dioxin-
mediated effects on the immune system challenging. Relatively recent studies revealing a 
role for the AHR in Th17 cells and Tregs led to increased interest in evaluating the 
effects of this transcription factor on immunity (Kimura et al., 2008; Quintana et al., 
2008; Veldhoen et al., 2008). As described in Chapter 1, subsequent work has identified 
multiple functions for the AHR in the immune system, particularly in the intestine.  
The experiments presented here contribute to this body of work by describing 
context-dependent effects of the AHR following oral and i.p. infection with T. gondii and 
a role for this transcription factor in NK cell production of IL-10. When taken together 
with other reports demonstrating that AHR activity promotes IL-10 production by 
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macrophages, dendritic cells, and T cells (Apetoh et al., 2010; Kimura et al., 2009; 
Nguyen et al., 2010), these studies indicate that the AHR is a conserved regulator of IL-
10 expression by innate and adaptive cells. Importantly, the effects of the AHR on IL-10 
production are context dependent, as suggested by the intact STAg-induced expression of 
IL-10 in cells from orally infected Ahr-/- mice (Chapter 3). Additional implications of this 
work and questions that it raises are discussed in the following sections.  
Challenges in using Ahr-/- mice 
One of the challenges in using Ahr-/- mice to study immunity is caused by the 
widespread phenotypic changes in these animals, which make identifying the precise 
mechanisms behind any infection-induced effects difficult. The altered liver morphology, 
vascular defects, and changes in commensal populations in Ahr-/- mice could have effects 
on outcomes of infection in addition to the broad roles for the AHR in multiple aspects of 
immunity. These studies are further complicated by the finding that AHR deficient mice 
generated in different laboratories can have markedly different phenotypes following 
infection (Lawrence and Vorderstrasse, 2013). As described in Chapter 3, some of these 
effects may be due to the extent to which different strains of Ahr-/- mice had been 
backcrossed (Esser, 2009). Further studies done in parallel with multiple strains of AHR 
deficient animals could clarify the basis for this observed phenotypic variability. Ahr-/- 
mice additionally have reproductive defects and decreased fertility, which need to be 
taken into account when breeding these animals (Baba et al., 2005). However, mice with 
floxed alleles of the AHR have been developed, and provide a useful tool for studying the 
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effects of AHR deficiency on specific cell types in vivo. Alternatively, studies in Ahr-/- 
mice could be complemented by experiments in which animals are administered AHR 
ligands or inhibitors (Denison and Nagy, 2003; Zhao et al., 2010), but many of these 
compounds are not soluble in chemicals that can readily be administered to mice. 
Although there are a number of challenges to working with fully AHR deficient mice, 
one advantage to this approach is that it provides a means to investigate the effects of a 
complete absence of AHR signaling in every cell type.  
Sources of AHR ligands 
The finding that the AHR affects immune responses to toxoplasmosis raises the 
question of what the relevant sources of ligands are in this setting. This consideration is 
important, as different AHR agonists can have disparate effects. For example, as 
described in Chapter 1, FICZ induces Th17 cells whereas dioxin promotes Treg 
development (Quintana et al., 2008). Similarly, the studies in this thesis found that FICZ 
promotes IL-10 production from NK cells but kynurenine does not (Chapter 2). These 
results raise the question of how various AHR agonists mediate different responses. The 
rate at which AHR ligands are metabolized could explain some of their differential 
effects; FICZ is metabolized rapidly but dioxin persists, which may contribute to its toxic 
consequences (Bergander et al., 2004; Neal, 1985). 
As detailed in Chapter 1, possible sources of AHR ligands during toxoplasmosis 
include the diet, commensal bacteria, the host immune response, or T. gondii. The 
prevalence of various AHR agonists in different sites of infection may explain some of 
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the disparate roles for this transcription factor during oral and chronic toxoplasmosis. 
Thus, dietary and microbiota-derived ligands may be particularly important during oral 
infection while high levels of the host-derived AHR agonist kynurenine are found in the 
brain during the chronic phase (Notarangelo et al., 2014). A potential role for dietary 
AHR ligands during toxoplasmosis could be tested by feeding infected mice diets that are 
low in AHR agonists, or conversely, by supplementing the diet with high-affinity AHR 
ligands. Recent insights into the roles for the diet and commensal bacteria as sources of 
AHR agonists that impact immunity (Kiss et al., 2011; Li et al., 2011; Zelante et al., 
2013) contribute to a growing appreciation of how food intake and the microbiota can 
influence the immune system. For example, dietary nutrients such as vitamin A have a 
number of effects on immune responses (Spencer and Belkaid, 2012), and the production 
of butyrate by commensal bacteria promotes the generation of Tregs (Arpaia et al., 2013; 
Furusawa et al., 2013). Sensing through the AHR provides an additional means through 
which the immune system can respond to dietary and microbiota-derived compounds. 
Importantly, the diet directly affects the composition of the intestinal microflora as 
different groups of bacteria compete for nutrients (Honda and Littman, 2012). Dietary 
compounds might also shape the intestinal microbiota indirectly by activating the AHR, 
which influences IL-22 production, group 3 innate lymphoid cells, and the expression of 
antimicrobial peptides (Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012; Veldhoen et 
al., 2008).  
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As discussed in Chapter 2, the production of AHR ligands by pathogens such as 
T. gondii raises the possibility that the AHR might also act as a sensor of pathogen-
derived metabolites. The immune system has been proposed to respond differently to 
living and dead microorganisms due to the detection of molecules such as bacterial 
mRNA, which serve as viability associated pathogen associated molecular patterns (vita-
PAMPs) (Sander et al., 2011). By acting through the AHR, metabolites produced by 
pathogens could potentially act as vita-PAMPs. Although previous work has shown that 
some of the consequences of AHR signaling are consistent with a role in innate sensing 
(see Chapter 1), no such effects of this transcription factor were observed following T. 
gondii infection. For example, Ahr-/- mice had no defect in IL-12 production by dendritic 
cells during acute toxoplasmosis (Chapter 2), and microglial activation in the chronic 
stage was comparable between wild-type and AHR deficient animals (Chapter 3). 
Additionally, although stimulation with the AHR agonist FICZ promoted NK cell IL-10 
production in vitro, treatment with STAg had no effect on NK cell IL-10 (data not 
shown). Although these results suggest that T. gondii is not a major source of AHR 
agonists following infection, the effects of parasite-derived ligands during toxoplasmosis 
remain unclear. A possible role for these compounds could be further evaluated by 
generating genetically manipulated parasites that are unable to catalyze the production of 
the AHR ligand lipoxin A4, but this not the only potential pathway through which T. 
gondii might create AHR agonists.  
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Parallels between the AHR and HIF1α  
As detailed in Chapter 1, increasing attention is being paid to the widespread and 
context dependent roles for the AHR and HIF1α in multiple aspects of innate and 
adaptive immunity. The parallels in the immunological functions of these transcription 
factors suggest that gaining an understanding of the roles of one pathway might also shed 
light on contributions of the other. For example, the effects of AHR signaling on group 3 
innate lymphoid cells and the intestinal microbiota raises the question of whether HIF1α 
might also influence these populations. Similarly, HIF1α has multiple effects in intestinal 
epithelial cells that promote barrier function, suggesting that the AHR may play a 
comparable role. The studies in this thesis describing a contribution of the AHR to NK 
cell IL-10 expression raise the question of whether HIF1α also affects cytokine 
production by these cells. Additionally, the effects of AHR signaling during oral and 
chronic toxoplasmosis suggest that HIF1α might affect responses to challenge with T. 
gondii. This is a particularly interesting question, given the finding that parasite growth is 
impaired in HIF1α deficient cells (Spear et al., 2006). Thus, while HIF1α might 
contribute to the immune response to toxoplasmosis, signaling through this transcription 
factor also promotes parasite replication. Although many studies have investigated the 
effects of AHR and HIF1α signaling in isolation, work that examines the effects of these 
transcription factors in parallel could provide valuable insight into how they function 
during immune responses to infection.  
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The striking parallels in the effects of the AHR and HIF1α on immune responses 
may be coincidental, but also raise the possibility that low oxygen and the presence of 
AHR ligands are interpreted by the immune system as being indicators of similar 
challenges that warrant similar responses. What might account for these parallels? One 
possibility is that AHR and HIF1α signaling may play an especially important role at 
barrier surfaces such as the skin and intestines, which are likely major sites of exposure to 
AHR ligands and are thought to be relatively hypoxic. In agreement with this notion, the 
work presented here found that Ahr-/- mice exhibited more dramatic phenotypic 
differences following oral infection with T. gondii than after i.p. challenge. Additionally, 
the AHR and HIF1α have been shown to promote responses such as the production of 
antimicrobial peptides and the generation of Th17 cells, which are critical at barrier 
surfaces (Berger et al., 2013; Dang et al., 2011; Kimura et al., 2008; Qiu et al., 2012; 
Quintana et al., 2008; Shi et al., 2011; Veldhoen et al., 2008). 
Sources of IL-10 during T. gondii infection 
 Studies described in Chapter 2 of this thesis using Vert-X IL-10 reporter mice 
identified multiple cellular sources of IL-10 following infection, in agreement with 
previous work (Perona-Wright et al., 2009). These results raise the question of whether 
IL-10 production from varying cell types has different functional effects during 
toxoplasmosis. Indeed, CD4+ T cells are a critical source of IL-10 following infection 
with T. gondii (Jankovic et al., 2007; Roers et al., 2004), indicating that IL-10 expression 
by other cell types is not sufficient to prevent lethal immune-mediated pathology. The 
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finding that IL-10-/- RAG2-/- mice reconstituted with IL-10 sufficient but not IL-10-/- 
CD4+ T cells survive T. gondii infection implies that innate sources of IL-10 are not 
essential during toxoplasmosis (Jankovic et al., 2007). The requirement for CD4+ T cell 
IL-10 may be due to the amount of IL-10 produced by these cells, the time post-infection 
at which IL-10 is produced by CD4+ T cells, or the specific microenvironment in which 
IL-10 is secreted by these cells. Interestingly, IL-10 is produced by Th1 cells that also 
express IFN-γ (Jankovic et al., 2007). The work presented in Chapter 2 indicated that NK 
cells expressing the IL-10 reporter during infection similarly produce high levels of IFN-
γ. These two cytokines have a number of functions that directly antagonize each other, 
raising the question of whether Th1 cells or NK cells simultaneously release IL-10 and 
IFN-γ in vivo and what effects these cytokines mediate when acting in concert.   
  Although innate sources of IL-10 may not be essential during toxoplasmosis, IL-
10 deficient SCID mice are more resistant to infection than SCID mice (Neyer et al., 
1997), indicating that innate IL-10 expression does have functional consequences. The 
finding that NK cells are a major early source of this cytokine raises the question of what 
effects NK cell IL-10 mediates. The production of IL-10 by NK cells has been suggested 
to limit the CD8+ T cell response following murine cytomegalovirus infection (Lee et al., 
2009) and NK cell IL-10 promotes increased parasite burdens during visceral 
leishmaniasis (Maroof et al., 2008). Similarly, in the studies in Chapter 2, the NK cell IL-
10 defect in Ahr-/- mice was associated with reduced parasite burdens. NK cell depletion 
studies during toxoplasmosis have suggested that IL-10 expression by these cells limits 
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IL-12 production (Perona-Wright et al., 2009), but NK cell depletion could also influence 
IL-12 levels by altering parasite burdens. Thus, although NK cells are a major early 
source of IL-10, it remains unclear how their production of this cytokine affects the 
immune response to toxoplasmosis. These effects could be further elucidated through the 
use of mice with an NK cell specific deletion of IL-10. However, the specificity of NK 
cell targeted Cre expression is a concern, as the commonly used NK cell marker NK1.1 is 
expressed by a variety of cell types including NK T cells and some activated CD8+ T 
cells (Wang et al., 2013). NKp46 driven Cre mice that have been developed (Eckelhart et 
al., 2011) may offer more specificity, but NKp46 is also expressed on other cell types, 
including a subset of group 3 ILCs.  
 Although IL-10 production plays a critical role in limiting pathology during acute 
and chronic toxoplasmosis (Gazzinelli et al., 1996; Jankovic et al., 2007; Wilson et al., 
2005), the cell populations that IL-10 needs to act on to mediate its protective effects are 
unclear. IL-10 was initially characterized as a factor produced by Th2 cells that inhibited 
Th1 cytokine production (Moore et al., 2001). Subsequent studies indicated that IL-10 
mediated consequences on T cell cytokine production were the indirect result of the 
effects of IL-10 on antigen presenting cells such as macrophages and dendritic cells 
(Moore et al., 2001). More recently, IL-10 signaling has been shown to affect regulatory 
T cells (Chaudhry et al., 2011; Murai et al., 2009), and it is unclear whether this function 
of IL-10 influences the phenotype of IL-10-/- mice during toxoplasmosis. The importance 
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of different populations of IL-10 responding cells during infection could be evaluated 
through the use of mice with cell type specific deletions of the IL-10 receptor. 
Possible functions of NK cell subsets 
 In addition to producing IL-10, the studies described in Chapter 2 found that NK 
cells upregulated the expression of T-bet and KLRG1 during infection, raising the 
question of how these molecules affect NK cell function. KLRG1 binds to E-cadherins 
and limits NK cell cytolytic activity (Ito et al., 2006). Thus, the population of NK cells 
emerging during infection that produces IL-10 and expresses high levels of KLRG1 may 
have a less cytotoxic and more immunoregulatory role.  
 As noted in Chapter 2, the subset of NK cells expressing high levels of T-bet and 
KLRG1 mirrors the phenotype of short lived effector CD8+ T cells. Studies describing 
NK cell memory responses raise the question of whether these cells form populations of 
short lived effectors and memory precursors like CD8+ T cells (Cooper et al., 2009; 
O'Leary et al., 2006; Paust et al., 2010). Additionally, the signals that regulate the 
generation of NK cell memory are not well understood, but the activity of IL-12 
contributes to this process (Sun et al., 2012). The results presented in Chapter 2 indicate 
that AHR activity promotes some of the IL-12-mediated effects on NK cells, and it is 
unclear whether this transcription factor also affects the establishment of NK cell 
memory populations.  
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Potential roles for group 3 ILCs during toxoplasmosis 
 The studies described in Chapter 3 found that the group 3 ILC population also 
exhibits phenotypic changes following infection. Interestingly, challenge with T. gondii 
led to a reduction in the frequency and number of RORγt+ ILCs in the lamina propria as 
well as decreased RORγt expression by these cells. Previous work has found that a subset 
of group 3 ILCs can downregulate RORγt expression and develop the ability to produce 
IFN-γ, a process that is promoted by IL-12 signals (Vonarbourg et al., 2010). A similar 
phenomenon may occur in response to the IL-12 that is expressed during oral 
toxoplasmosis. Notably, the downregulation of group 3 ILC RORγt is associated with the 
proliferation of these cells (Vonarbourg et al., 2010), and an increased frequency of group 
3 ILCs expressed Ki67 following challenge with T. gondii (Chapter 3). RORγt GFP 
reporter mice could be utilized to assess the fate of RORγt+ ILCs during toxoplasmosis 
by transferring congenically marked group 3 ILCs from these mice into infected animals.  
 The observed decrease in the lamina propria RORγt+ ILC population during 
toxoplasmosis raises the question of whether the infection-induced changes in these cells 
have functional consequences. Given the role of group 3 ILCs in promoting the 
anatomical containment of commensal bacteria (Sonnenberg et al., 2012), a reduction in 
this cell population could contribute to the barrier dysfunction and microbial 
translocation that has been observed during toxoplasmosis (Benson et al., 2009; Hand et 
al., 2012). Since group 3 ILCs promote tolerance to commensal bacteria (Hepworth et al., 
2013), decreases in this cell population might facilitate the induction of immune 
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responses to infection. This effect would be analogous to the suggestion that the Treg 
crash seen during T. gondii infection promotes the generation of protective immunity by 
diminishing the immunosuppressive effects of Tregs (Benson et al., 2012). However, an 
increased frequency of RORγt+ ILCs expressed MHC II and CD80 during toxoplasmosis, 
suggesting that these cells might promote the development of adaptive immune responses 
following infection. The functional effects of group 3 ILCs are challenging to assess in 
vivo, because these cells are characterized by the absence of numerous of surface 
markers, which makes them difficult to deplete or target through genetic approaches. 
However, strategies to deplete these cells in RAG deficient chimeric mice have been 
developed (Sonnenberg et al., 2012), providing a means to interrogate the effects of 
RORγt+ ILCs during toxoplasmosis. Additionally, T. gondii infection of mice with an 
RORγt driven deletion of the AHR (Kiss et al., 2011) could address whether group 3 
ILCs in the lamina propria contribute to the immune response following challenge.  
Epidemiological and therapeutic implications of the effects of the AHR on immunity 
Given the presence of numerous compounds that activate the AHR in 
environmental pollution, findings that the AHR influences immune responses to T. gondii 
as well as a number of other infections (see Chapter 1) suggest that the effects of AHR 
signaling on the immune system may have epidemiological consequences. The effects of 
the AHR in promoting Th17 generation and the development of experimental 
autoimmune encephalomyelitis led to the suggestion that signaling through this 
transcription factor might contribute to the increasing rates of autoimmunity seen in 
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highly industrialized countries (Veldhoen et al., 2008). Notably, in addition to its role in 
autoimmune disease, AHR activity has a number of effects on immune responses to 
infection, suggesting that AHR signaling in response to changing exposure to 
environmental ligands may impact human health. Indeed, epidemiologic studies indicate 
that elevated exposure to pollutants that activate the AHR is associated with increased 
incidences of ear infections, chicken pox, and respiratory infections in children 
(Weisglas-Kuperus et al., 2000; Weisglas-Kuperus et al., 2004; Yu et al., 1998).  
 Findings describing multiple effects of the AHR on immune responses have also 
led to interest in targeting this pathway therapeutically. Although transcription factors are 
generally regarded as poor drug targets, the ligand dependent nuclear hormone receptors, 
which include immunologically relevant proteins such as retinoic acid receptors and 
peroxisome proliferator-activated receptors, are considered “druggable” (Blumberg and 
Evans, 1998; Shi, 2007). The AHR is structurally distinct from nuclear hormone 
receptors, but signaling through the AHR is analogous to nuclear hormone receptor 
function in that ligand binding induces transcriptional activity. The availability of various 
compounds that modulate AHR activity suggests that it may be possible to manipulate 
this pathway for therapeutic benefit (Denison and Nagy, 2003; Zhao et al., 2010). Studies 
in which AHR ligands have been delivered in nanoparticles (Quintana et al., 2010) 
indicate that it may be possible to alter AHR activity in specific cell types for therapeutic 
purposes. However, gaining an understanding of the context dependent effects of AHR 
signaling is essential in effectively targeting this transcription factor.  
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